conjunctival haemorrhage

H7_CONJUHAEMOR

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H11.3 Cause of death: ICD-10 — H11.3 2 out of 7 registries used, show all original rules.	3026
4. Check minimum number of events None	3026
5. Include endpoints None	3026
6. Filter based on genotype QC (FinnGen only)	2926

Control definitions (FinnGen only)

Control exclude: H7_CONJUNCTIVA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H11
Name in latin: Haemorrhagia conjunctivae

NAME	H7_CONJUHAEMOR
CONTROL_EXCLUDE	H7_CONJUNCTIVA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H113
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H113
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to conjunctival haemorrhage based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17760	9353	8327
Only index persons	16686	8922	7764
Unadjusted period prevalence (%)
Whole population	0.25	0.27	0.23
Only index persons	0.31	0.33	0.30
Median age at first event (years)
Whole population	63.98	65.11	62.79
Only index persons	64.10	65.11	62.94

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2926	1619	1307
Unadjusted period prevalence (%)	0.59	0.57	0.60
Median age at first event (years)	65.63	64.07	67.56

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3026: Matched controls
30260

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H11.3

ICD-10 Finland

Conjunctival haemorrhage

12698.0

307.7

3009

416

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

6.7

181.3

305

498

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.6

145.2

1647

9465

H04.10

ICD-10 Finland

Dry eye syndrome

3.3

114.2

486

1640

H20.1

ICD-10 Finland

Chronic iridocyclitis

11.5

102.4

107

H57.1

ICD-10 Finland

Ocular pain

5.0

87.7

195

409

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

2.1

85.0

1244

7460

S01GX01

ATC

cromoglicic acid; ophthalmic

2.7

81.9

502

2056

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.4

77.7

687

3338

F02

ICPC

Red eye

4.1

75.9

219

564

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

4.1

75.1

216

555

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.6

70.6

462

1946

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

65.0

1010

6055

H15.1

ICD-10 Finland

Episcleritis

8.2

63.7

106

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.3

62.6

584

2876

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

3.7

62.6

208

591

H02AB06

ATC

prednisolone; systemic

1.8

54.4

1519

10825

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

52.3

1107

7231

M79.6

ICD-10 Finland

Pain in limb

1.8

51.8

1321

9121

F29

ICPC

Eye symptom/complaint other

2.5

49.0

335

1429

R51.80

ICD-10 Finland

Headache

2.2

48.2

494

2505

B01AA03

ATC

warfarin; systemic

1.9

47.6

718

4186

S05.0

ICD-10 Finland

Injury of conjunctiva and corneal abrasion without mention of foreign body

5.1

47.3

101

204

S01BA01

ATC

dexamethasone; ophthalmic

3.8

47.2

150

413

R42

ICD-10 Finland

Dizziness and giddiness

1.9

45.9

781

4730

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

7.0

45.8

102

S18

ICPC

Laceration/cut

1.7

44.0

1472

10809

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

43.2

1514

11234

XCH00

NOMESCO Finland

Eye pressure measurement

3.0

42.6

199

696

H43.8

ICD-10 Finland

Other disorders of vitreous body

2.3

42.4

361

1693

S05.9

ICD-10 Finland

Injury of eye and orbit, unspecified

8.4

41.6

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

41.3

810

5101

A02BC02

ATC

pantoprazole; systemic

1.7

40.7

2102

17173

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.2

40.7

369

1775

H16.0

ICD-10 Finland

Corneal ulcer

3.1

39.6

177

604

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

39.5

852

5504

R06.0

ICD-10 Finland

Dyspnoea

1.7

39.3

892

5846

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

38.4

1227

8799

S01GX08

ATC

ketotifen; ophthalmic

4.1

38.1

106

265

XCK00

NOMESCO Finland

Perimetry

2.6

37.9

240

984

J01DB01

ATC

cefalexin; oral

1.8

37.3

2453

21148

S01BA04

ATC

prednisolone; ophthalmic

4.2

37.1

240

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

37.0

945

6377

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

36.8

1101

7741

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

36.5

778

4990

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

2.8

36.1

189

703

A02BC05

ATC

esomeprazole; systemic

1.6

35.9

1238

9006

S01ED01

ATC

timolol; ophthalmic

3.2

35.6

149

489

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

35.0

589

3518

L04AA06

ATC

mycophenolic acid; systemic

4.5

34.9

196

R03AC02

ATC

salbutamol; inhalant

1.6

34.7

1569

12156

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

34.7

2017

16608

L17

ICPC

Foot/toe symptom/complaint

1.7

34.7

892

6011

S05.1

ICD-10 Finland

Contusion of eyeball and orbital tissues

5.2

34.3

136

N02AX02

ATC

tramadol; systemic, rectal

1.6

34.2

1316

9802

UJF32

NOMESCO Finland

Coloscopy

1.7

34.1

853

5700

R05

ICPC

Cough

1.7

33.8

733

4710

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

33.6

551

3259

S01ED51

ATC

timolol, combinations; ophthalmic

2.2

33.6

296

1403

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.9

33.5

162

577

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

33.2

618

3798

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

33.0

922

6330

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

32.9

582

3522

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

32.7

1558

12152

N02BE01

ATC

paracetamol; systemic, rectal

2.0

32.7

2686

24100

M54.5

ICD-10 Finland

Low back pain

1.6

32.6

1041

7387

R06AE07

ATC

cetirizine; oral

1.6

32.5

1193

8751

S01FA04

ATC

cyclopentolate; ophthalmic

5.5

32.4

117

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

32.2

1224

9047

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

32.2

572

3464

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

32.1

1197

8806

R01AD12

ATC

fluticasone furoate; nasal

1.7

32.1

821

5505

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

6.0

31.7

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

31.7

232

1016

F01

ICPC

Eye pain

3.7

31.4

102

285

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.5

31.4

206

858

E0000UV, ,

ATC

1.6

31.3

1179

8683

M45

ICD-10 Finland

Ankylosing spondylitis

4.2

31.3

209

G47.3

ICD-10 Finland

Sleep apnoea

1.7

31.2

675

4321

127

Kela drug reimbursment

Transplant complication

4.8

31.1

148

AA1AD

NOMESCO Finland

CT of head and brain

1.6

31.1

898

6202

R03DC03

ATC

montelukast; oral

1.9

31.0

469

2700

N03AX16

ATC

[U] pregabalin

1.7

30.2

720

4725

R01AD58

ATC

fluticasone, combinations; nasal

1.7

30.0

606

3802

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

29.8

621

3928

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

29.7

808

5483

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

29.4

626

3982

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

29.2

915

6424

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

29.2

500

2988

R05

ICD-10 Finland

Cough

1.7

28.9

647

4169

R53

ICD-10 Finland

Malaise and fatigue

1.7

28.1

698

4619

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

27.7

1293

9908

XF404

NOMESCO Finland

Ambulatory ECG

2.0

27.6

308

1595

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.9

27.5

354

1929

R74

ICPC

Upper respiratory infection acute

1.6

27.5

762

5182

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

27.4

379

2114

A01

ICPC

Pain general/multiple sites

2.0

27.3

303

1566

L04AX01

ATC

azathioprine; systemic

2.7

27.1

146

551

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

26.9

1800

14853

H26.4

ICD-10 Finland

After-cataract

1.9

26.7

355

1955

R52.9

ICD-10 Finland

Pain, unspecified

2.0

26.6

303

1580

R07.3

ICD-10 Finland

Other chest pain

2.0

26.6

330

1774

R01AD09

ATC

mometasone; nasal

1.5

26.6

1201

9115

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

26.6

600

3866

J01FA10

ATC

azithromycin; systemic

1.5

26.5

1529

12212

G44.2

ICD-10 Finland

Tension-type headache

1.9

26.5

386

2188

J01AA02

ATC

doxycycline; systemic

1.6

26.3

2279

19853

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.0

26.3

306

1609

SPAT1263

SPAT

Sampling

1.5

25.9

1222

9344

ZYC01

NOMESCO Finland

Remote contact by phone

2.4

25.9

187

813

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

25.8

738

5043

L01

ICPC

Neck symptom/complaint

1.8

25.8

444

2648

L03

ICPC

Low back symptom/complaint

1.6

25.8

790

5488

Z00.0

ICD-10 Finland

General medical examination

1.7

25.7

582

3748

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

4.6

25.5

132

Z71.8

ICD-10 Finland

Other specified counselling

1.6

25.4

840

5939

K78

ICPC

Atrial fibrillation/flutter

2.0

25.3

288

1501

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

25.3

1061

7903

SPAT1260

SPAT

Consultation of another employee

1.7

25.3

543

3448

J01FA06

ATC

roxithromycin; oral

1.5

24.8

1144

8685

R01AD08

ATC

fluticasone; nasal

1.6

24.8

747

5162

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

24.7

793

5563

SFA10

NOMESCO Finland

One-surface restoration

1.5

24.7

1492

11966

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

24.5

1986

16891

207

Kela drug reimbursment

Chronic arrhythmias

1.7

24.3

540

3456

M03BX02

ATC

tizanidine; oral

1.5

24.2

1701

14034

R60.0

ICD-10 Finland

Localized oedema

1.8

24.2

398

2340

J01CA04

ATC

amoxicillin; systemic

1.6

24.2

2318

20406

SPAT1153

SPAT

Removal of sutures

1.5

24.2

983

7258

L04AX03

ATC

methotrexate; systemic

2.0

24.1

299

1605

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

24.1

191

864

114

Kela drug reimbursment

Glaucoma

1.9

24.0

307

1665

H01.0

ICD-10 Finland

Blepharitis

2.4

24.0

170

733

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

23.8

386

2259

R50.9

ICD-10 Finland

Fever, unspecified

1.8

23.7

439

2673

M79.1

ICD-10 Finland

Myalgia

1.8

23.6

399

2364

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

23.6

268

1395

SFA20

NOMESCO Finland

Two-surface restoration

1.5

23.5

1570

12794

SPAT1312

SPAT

General health counselling

1.5

23.5

896

6518

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

23.4

1117

8512

H02AB04

ATC

methylprednisolone; systemic

1.8

23.4

431

2619

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.0

23.3

284

1516

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

23.1

316

1752

S06.0

ICD-10 Finland

Concussion

1.9

23.0

318

1769

R06AX27

ATC

desloratadine; oral

1.6

23.0

673

4607

ZXA00

NOMESCO Finland

Right side

1.5

22.8

810

5796

M25.5

ICD-10 Finland

Pain in joint

1.5

22.7

872

6342

J01FF01

ATC

clindamycin; systemic

1.5

22.5

770

5461

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

22.5

536

3488

J01MA02

ATC

ciprofloxacin; systemic

1.5

22.4

1132

8708

C07AB07

ATC

bisoprolol; oral

1.5

22.4

1505

12233

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

22.2

556

3661

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.1

22.2

214

1048

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.9

22.2

277

1490

L82

ICD-10 Finland

Seborrhoeic keratosis

1.6

22.1

556

3666

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

22.1

331

1890

CKC12

NOMESCO Finland

Photocoagulation of retina

2.5

22.0

143

592

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

22.0

655

4496

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

21.8

307

1717

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

21.7

438

2726

L15

ICPC

Knee symptom/complaint

1.6

21.6

699

4890

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

21.5

425

2629

C01BC04

ATC

flecainide; systemic

2.6

21.4

129

515

UKC02

NOMESCO Finland

Cystoscopy

1.7

21.4

504

3265

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

21.4

1030

7830

J01FA09

ATC

clarithromycin; systemic

1.5

21.2

831

6053

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

21.2

1261

9976

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

6.0

21.2

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

21.2

1186

9277

H26.2

ICD-10 Finland

Complicated cataract

4.3

21.2

131

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.6

21.0

122

479

Z01.2

ICD-10 Finland

Dental examination

1.5

20.9

1187

9301

C03CA01

ATC

furosemide; systemic

1.5

20.8

958

7207

H10.4

ICD-10 Finland

Chronic conjunctivitis

21.6

20.8

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

4.3

20.7

125

R03BA05

ATC

fluticasone; inhalant

1.6

20.6

492

3196

TFP20

NOMESCO Finland

Cardiodefibrillation

2.0

20.5

247

1312

H26.3

ICD-10 Finland

Drug-induced cataract

6.5

20.5

AN1

Coronary angiography

1.7

20.3

371

2243

L12

ICPC

Hand/finger symptom/complaint

1.7

20.2

437

2769

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.1

20.0

210

1061

N03AX12

ATC

[U] gabapentin; oral

1.6

20.0

486

3169

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

19.9

634

4407

A46

ICD-10 Finland

Erysipelas

1.7

19.9

449

2875

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

19.8

389

2399

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

19.8

253

1370

R02

ICPC

Shortness of breath/dyspnoea

1.7

19.7

393

2433

S01XA18

ATC

ciclosporin; ophthalmic

7.8

19.5

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

19.4

1399

11405

R03BA08

ATC

ciclesonide; inhalant

1.9

19.3

246

1331

S01GX05

ATC

lodoxamide; ophthalmic

5.8

19.3

R04.0

ICD-10 Finland

Epistaxis

1.9

19.3

252

1375

J01DA01

ATC

[U] cefalexin

1.4

19.3

1721

14563

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

19.3

856

6377

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

19.2

364

2223

K02.1

ICD-10 Finland

Caries of dentine

1.4

19.2

1538

12766

M54.6

ICD-10 Finland

Pain in thoracic spine

2.0

19.1

204

1037

XF402

NOMESCO Finland

ECG with work load test

1.8

19.1

338

2023

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

19.1

914

6906

SFA30

NOMESCO Finland

Three-surface restoration

1.4

19.1

1149

9062

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

19.1

723

5214

R51

ICD-10 Finland

Headache

2.3

18.9

143

635

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

18.8

144

643

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

18.8

492

3266

H01

ICPC

Ear pain/earache

1.8

18.7

289

1664

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.5

18.5

121

503

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

18.5

636

4490

R23.3

ICD-10 Finland

Spontaneous ecchymoses

3.1

18.4

243

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

18.4

193

976

M48.0

ICD-10 Finland

Spinal stenosis

1.7

18.3

395

2495

KMAK, ,

NOMESCO Finland

1.4

18.3

1328

10799

UDC00

NOMESCO Finland

Ear microscopy

1.9

18.3

224

1196

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

18.2

221

1176

P01AB01

ATC

metronidazole; oral, rectal

1.4

18.1

1076

8444

L04AD01

ATC

ciclosporin; systemic

3.4

18.0

200

B01AF02

ATC

apixaban; oral

1.6

18.0

416

2676

L01BA01

ATC

methotrexate; systemic

2.4

18.0

120

504

B01AB05

ATC

enoxaparin; parenteral

1.4

17.9

932

7135

-1, ,

NOMESCO Finland

1.5

17.9

835

6262

SPAT1325

SPAT

Vaccination

1.4

17.9

987

7639

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

17.9

222

1191

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

17.8

309

1839

A02BC03

ATC

lansoprazole; oral

1.5

17.8

828

6206

SPAT1310

SPAT

Counselling related to known health issue

1.4

17.7

889

6757

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

17.7

251

1405

J01MA14

ATC

moxifloxacin; systemic

1.8

17.6

268

1534

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.9

17.6

246

1371

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.5

17.6

107

430

S01EE01

ATC

latanoprost; ophthalmic

1.9

17.6

214

1140

H40.0

ICD-10 Finland

Glaucoma suspect

1.9

17.5

247

1380

M50.3

ICD-10 Finland

Other cervical disc degeneration

3.0

17.5

266

S29

ICPC

Skin symptom/complaint other

1.6

17.5

539

3708

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

17.5

375

2364

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

17.5

1857

16061

S01BC03

ATC

diclofenac; ophthalmic

3.0

17.5

256

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

3.1

17.5

235

D82

ICPC

Teeth/gum disease

1.4

17.4

909

6957

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

17.4

204

1073

C01CA24

ATC

epinephrine; parenteral

2.2

17.3

149

698

S01GX02

ATC

levocabastine; ophthalmic

2.5

17.2

107

435

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

17.1

349

2171

Z3231

NOMESCO Finland

Registered nurse

1.5

17.1

766

5694

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

17.0

289

1709

D07AC01

ATC

betamethasone; topical

1.4

16.9

989

7720

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

16.8

557

3892

S01EE05

ATC

tafluprost; ophthalmic

2.3

16.7

122

533

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

16.6

525

3628

H02AB07

ATC

prednisone; oral

1.6

16.6

387

2490

J01MA12

ATC

levofloxacin; systemic

1.5

16.6

536

3721

K30

ICD-10 Finland

Functional dyspepsia

1.7

16.6

302

1820

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

16.6

253

1449

R21

ICPC

Throat symptom/complaint

1.6

16.5

455

3048

S01EA05

ATC

brimonidine; ophthalmic

2.7

16.5

331

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

16.5

543

3788

H29

ICPC

Ear symptom/complaint other

1.7

16.4

328

2028

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

16.4

385

2482

SPAT1229

SPAT

Assessment of need for aid

1.8

16.4

249

1424

R07.0

ICD-10 Finland

Pain in throat

2.0

16.4

170

856

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

16.3

256

1478

SPAT1301

SPAT

No procedures

1.4

16.3

891

6858

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

16.3

290

1737

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

16.3

635

4585

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

16.3

1191

9641

S01GX09

ATC

olopatadine; ophthalmic

3.6

16.2

154

R51.81

ICD-10 Finland

Facial pain NOS

2.9

16.2

267

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

16.2

469

3177

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

16.2

288

1726

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.1

16.1

166

833

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

16.1

438

2926

J01DA09

ATC

[U] cefadroxil

1.5

15.9

687

5057

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

15.9

446

3001

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

15.8

296

1798

ZXA10

NOMESCO Finland

Bilateral

1.5

15.8

536

3761

S16

ICPC

Bruise/contusion

2.4

15.7

105

441

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.1

15.7

143

685

S01FA02

ATC

scopolamine; ophthalmic

4.4

15.7

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

15.7

424

2828

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

15.6

372

2407

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

15.6

289

1751

R03AC03

ATC

terbutaline; inhalant

1.6

15.5

360

2313

S01EC04

ATC

brinzolamide; ophthalmic

2.2

15.5

137

649

H15.0

ICD-10 Finland

Scleritis

13.8

15.5

A98

ICPC

Health maint/preventive medicine

1.9

15.5

2845

27015

ZXA05

NOMESCO Finland

Left side

1.4

15.4

719

5367

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

15.4

328

2061

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.9

15.4

208

1146

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

15.4

149

731

R00.2

ICD-10 Finland

Palpitations

1.9

15.4

202

1103

Z00.8

ICD-10 Finland

Other general examinations

1.9

15.4

204

1118

X58

ICD-10 Finland

Exposure to other specified factors

1.6

15.4

357

2294

E000001, ,

ATC

1.5

15.3

499

3469

R03BA02

ATC

budesonide; inhalant

1.5

15.3

458

3125

M02AA07

ATC

piroxicam; topical

1.4

15.2

1022

8130

ZXE00

NOMESCO Finland

One hour or less

1.4

15.2

1041

8309

N06AX21

ATC

duloxetine; oral

1.7

15.2

308

1912

A02BC01

ATC

omeprazole; systemic

1.4

15.1

752

5677

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

15.1

223

1264

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.2

15.1

131

616

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

15.1

182

967

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

15.1

727

5459

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

2.0

15.0

156

787

SDA03

NOMESCO Finland

Periodontal treatment

1.4

14.9

994

7890

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

14.9

524

3700

S01EA03

ATC

apraclonidine; ophthalmic

4.2

14.8

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

14.8

401

2672

L02

ICPC

Back symptom/complaint

1.8

14.8

249

1467

XQ800

NOMESCO Finland

Prick test

2.0

14.8

170

888

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.3

14.8

164

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

14.8

213

1199

L57.0

ICD-10 Finland

Actinic keratosis

1.6

14.8

337

2156

J46

ICD-10 Finland

Status asthmaticus

2.5

14.7

363

R96

ICPC

Asthma

1.7

14.7

271

1639

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

14.6

273

1656

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.6

14.6

317

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

14.6

1117

9063

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

14.6

1020

8157

J05AB01

ATC

aciclovir; systemic

1.5

14.6

573

4136

H36.01

ICD-10 Finland

Diabetic maculopathy

3.5

14.5

146

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

4.0

14.5

100

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

14.5

165

859

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

14.5

240

1408

J20

ICD-10 Finland

Acute bronchitis

1.7

14.5

268

1623

C10AA07

ATC

rosuvastatin; oral

1.4

14.4

902

7077

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

14.4

237

1387

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

14.4

203

1134

C10AA05

ATC

atorvastatin; oral

1.4

14.4

1246

10301

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.4

14.3

K08.80

ICD-10 Finland

Toothache NOS

1.8

14.2

205

1153

H11.4

ICD-10 Finland

Other conjunctival vascular disorders and cysts

19.2

14.2

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

22.4

14.2

WX002

NOMESCO Finland

Sedation and analgesia

1.5

14.2

557

4017

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

14.1

110

495

L04AD02

ATC

tacrolimus; systemic

4.2

14.1

R03BA01

ATC

beclometasone; inhalant

1.6

14.1

370

2447

A02BA02

ATC

ranitidine; systemic

1.5

14.1

544

3909

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.0

14.1

143

715

WZC30

NOMESCO Finland

Teaching

1.5

13.9

456

3167

SFA00

NOMESCO Finland

Small restoration

1.6

13.9

361

2381

WW200, ,

SPAT

1.4

13.9

628

4650

N02BF01

ATC

gabapentin; oral

1.8

13.8

229

1343

S01EC01

ATC

acetazolamide; systemic

2.8

13.8

257

Z94.0

ICD-10 Finland

Kidney transplant status

3.9

13.8

104

B07.9

ICD-10 Finland

Verruca simplex

2.4

13.8

406

S04

ICPC

Lump/swelling localized

1.7

13.7

273

1685

A04

ICPC

Weakness/tiredness general

1.6

13.7

392

2643

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

13.6

698

5286

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

13.6

201

1140

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

13.6

218

1267

M54.2

ICD-10 Finland

Cervicalgia

1.8

13.5

211

1216

F75

ICPC

Contusion/haemorrhage eye

11.0

13.5

S97

ICPC

Chronic ulcer skin

1.8

13.4

190

1063

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

13.4

192

1078

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

13.4

452

3157

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

13.4

279

1742

S01BA07

ATC

fluorometholone; ophthalmic

3.2

13.4

164

R11

ICD-10 Finland

Nausea and vomiting

1.7

13.4

234

1395

A11

ICPC

Chest pain NOS

1.7

13.3

239

1434

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.9

13.3

169

913

K80

ICPC

Cardiac arrhythmia NOS

1.7

13.3

235

1404

L09

ICPC

Arm symptom/complaint

2.1

13.3

129

634

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.9

13.3

166

893

L29

ICPC

Musculoskeletal sympt/complt other

1.7

13.2

238

1429

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

13.2

158

837

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

13.2

177

974

S20.2

ICD-10 Finland

Contusion of thorax

2.0

13.1

150

782

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.9

13.1

159

846

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

13.1

761

5881

N06AB04

ATC

citalopram; systemic

1.5

13.1

541

3936

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

13.0

892

7080

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

11.0

13.0

H11.1

ICD-10 Finland

Conjunctival degenerations and deposits

28.5

12.9

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.8

12.9

190

1076

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

12.9

502

3608

J02AC01

ATC

fluconazole; systemic

1.4

12.9

962

7737

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

12.8

363

2441

K99

ICPC

Cardiovascular disease other

2.3

12.8

407

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

12.7

657

4975

R39.1

ICD-10 Finland

Other difficulties with micturition

2.3

12.6

397

L28

ICPC

Limited function/disability (L)

1.5

12.6

517

3755

D01

ICPC

Abdominal pain/cramps general

1.6

12.5

290

1860

M01AH05

ATC

etoricoxib; oral

1.3

12.5

1634

14233

XKD00

NOMESCO Finland

Uroflowmetry

1.5

12.5

449

3177

R31

ICD-10 Finland

Unspecified haematuria

1.6

12.4

296

1911

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.2

12.4

104

483

J45

ICD-10 Finland

Asthma

1.7

12.4

255

1587

S01GX06

ATC

emedastine; ophthalmic

4.9

12.4

H3603, E103,

ICD-10 Finland

4.4

12.4

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

12.4

388

L04AA01

ATC

[U] ciclosporin

3.3

12.3

142

CHF05

NOMESCO Finland

Transscleral laser coagulation of ciliary body

5.8

12.3

I20.09

ICD-10 Finland

Unstable angina

1.8

12.2

176

991

R03AK08

ATC

formoterol and beclometasone; inhalant

2.1

12.2

122

607

B01AC04

ATC

clopidogrel; oral

1.5

12.2

494

3576

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

12.1

634

4804

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

12.1

463

3312

ZXD05

NOMESCO Finland

Urgent procedure

1.4

12.1

790

6209

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

12.1

147

783

R4110, ,

SPAT

1.7

12.1

243

1503

P01

ICPC

Feeling anxious/nervous/tense

1.7

12.1

215

1287

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

12.1

292

1892

S01BC05

ATC

ketorolac; ophthalmic

2.1

12.1

115

562

H34.8

ICD-10 Finland

Other retinal vascular occlusions

2.5

12.0

312

L08

ICPC

Shoulder symptom/complaint

1.4

12.0

589

4415

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

12.0

225

1368

N01

ICPC

Headache

1.7

11.9

233

1431

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.5

11.9

290

C07AA05

ATC

propranolol; systemic

1.5

11.9

489

3549

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

11.9

217

1309

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

11.8

173

978

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

11.8

692

5341

EB1VA, ,

NOMESCO Finland

1.6

11.8

304

1999

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.1

11.8

108

520

C09CA06

ATC

candesartan; oral

1.4

11.8

628

4773

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

11.7

543

4026

SCA01

NOMESCO Finland

Preventive oral health care, short

1.4

11.7

662

5080

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

2.1

11.7

113

555

WX140

NOMESCO Finland

Parabulbar anesthesy

1.9

11.7

141

750

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

11.7

177

1012

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

11.6

175

998

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

11.6

205

1224

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.3

11.6

373

I50.0

ICD-10 Finland

Congestive heart failure

1.7

11.6

221

1347

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.2

11.6

431

SPAT1254

SPAT

Administration of medicine

1.5

11.6

409

2880

D06

ICPC

Abdominal pain localized other

1.7

11.6

214

1295

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

11.5

727

5679

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

11.5

441

3156

C01DA14

ATC

isosorbide mononitrate; oral

1.5

11.5

460

3320

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

11.5

656

5042

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

11.5

414

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.4

11.4

326

W19

ICD-10 Finland

Unspecified fall

1.6

11.4

263

1685

I49.5

ICD-10 Finland

Sick sinus syndrome

2.0

11.4

119

602

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

11.4

202

1209

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.9

11.4

154

851

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

11.3

313

2091

N17

ICPC

Vertigo/dizziness

1.5

11.3

345

2357

F13

ICPC

Eye sensation abnormal

2.4

11.3

328

TK800

NOMESCO Finland

Hemodialysis

2.6

11.2

262

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

11.2

289

1900

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

11.2

764

6036

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

11.2

947

7726

C09CA01

ATC

losartan; oral

1.4

11.2

735

5775

W44

ICD-10 Finland

Foreign body entering into or through eye or natural orifice

3.0

11.1

167

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.1

11.1

104

505

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.7

11.0

199

1196

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

11.0

427

L60.0

ICD-10 Finland

Ingrowing nail

1.9

11.0

127

665

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

2.1

11.0

107

527

SPAT1211

SPAT

Application of soft bandage

1.6

11.0

241

1524

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

11.0

217

1337

S80.0

ICD-10 Finland

Contusion of knee

1.8

11.0

175

1016

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

4.5

10.9

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

10.9

174

1010

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.2

10.9

449

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.3

10.8

372

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.2

10.8

385

A07AA02

ATC

nystatin; oral

1.8

10.8

165

946

SPAT1097

SPAT

Recording of ECG

1.5

10.8

421

3021

S01AD03

ATC

aciclovir; ophthalmic

2.2

10.8

425

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.8

10.8

187

C08CA02

ATC

felodipine; oral

1.6

10.7

276

1816

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

10.7

1215

10305

M01AX17

ATC

nimesulide; oral

1.4

10.7

662

5147

K03.00

ICD-10 Finland

Approximal wear

1.8

10.7

172

1002

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

10.7

283

1874

WYA10

NOMESCO Finland

Emergency care or similar visit

1.7

10.7

177

1040

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

3.6

10.6

WZC30, ,

SPAT

1.8

10.6

155

877

F03

ICPC

Eye discharge

1.8

10.6

151

848

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

10.6

285

1894

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.6

10.5

259

1685

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

10.5

174

1021

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.9

10.5

124

655

H33.0

ICD-10 Finland

Retinal detachment with retinal break

2.2

10.5

403

D07AC13

ATC

mometasone; topical

1.3

10.5

732

5794

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

14.2

10.5

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

10.4

205

1261

D19

ICPC

Teeth/gum symptom/complaint

1.4

10.4

656

5110

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

10.4

424

C05AA08

ATC

fluocortolone; rectal, topical

1.5

10.4

360

2522

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.2

10.4

398

D02

ICPC

Abdominal pain epigastric

1.8

10.4

156

890

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

10.4

289

1934

K07.60

ICD-10 Finland

Snapping jaw

2.0

10.4

110

560

P01BA02

ATC

hydroxychloroquine; oral

1.7

10.4

214

1334

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

10.3

688

5405

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

10.3

282

1879

F27

ICPC

Fear of eye disease

3.8

10.3

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

10.3

147

827

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

10.2

137

755

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

10.2

559

4259

SPAT1043

SPAT

Audiometry

1.5

10.2

300

2033

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

10.1

184

1109

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

10.1

205

1272

C08CA13

ATC

lercanidipine; oral

1.4

10.1

414

2997

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

4.2

10.1

R06AE09

ATC

levocetirizine; oral

1.5

10.1

304

2070

-44

ICPC

Preventive immunization/medic

1.6

10.1

233

1494

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

10.1

359

2531

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

10.0

1001

8325

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

10.0

113

588

J01EA01

ATC

trimethoprim; systemic

1.3

10.0

679

5346

S02.30

ICD-10 Finland

Fracture of orbital floor, closed

3.7

10.0

C01AA05

ATC

digoxin; systemic

1.6

10.0

230

1474

XCW10

NOMESCO Finland

Assessment of vision

2.8

10.0

167

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

9.9

166

977

A03

ICPC

Fever

1.5

9.9

361

2555

S02.51

ICD-10 Finland

Fracture of tooth, open

1.6

9.9

244

1588

H25.8

ICD-10 Finland

Other senile cataract

1.5

9.9

331

2304

QDB10, ,

SPAT

2.6

9.9

225

C10AX09

ATC

ezetimibe; oral

1.4

9.9

434

3182

B01AE07

ATC

dabigatran etexilate; oral

1.9

9.9

120

641

K04

ICPC

Palpitations/awareness of heart

1.8

9.8

138

772

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

9.8

536

4079

M01AH02

ATC

rofecoxib; oral

1.5

9.8

340

2383

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

9.8

395

M01AE02

ATC

naproxen; oral, rectal

1.3

9.8

1453

12703

S01EE03

ATC

bimatoprost; ophthalmic

2.2

9.7

344

L14

ICPC

Leg/thigh symptom/complaint

1.6

9.7

212

1340

ZX120

NOMESCO Finland

Intravenous

1.6

9.7

254

1676

H25.0

ICD-10 Finland

Senile incipient cataract

1.7

9.7

193

1192

SPAT1262

SPAT

Handing over of treatment supplies

1.4

9.7

488

3663

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.0

9.6

485

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.4

9.6

270

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.3

9.6

320

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

9.6

251

1655

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

9.6

403

2928

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

9.6

427

3135

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

9.6

224

1439

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

3.7

9.6

R03AC13

ATC

formoterol; inhalant

1.8

9.6

130

720

EBA00

NOMESCO Finland

Extraction of tooth

1.3

9.5

895

7374

P06

ICPC

Sleep disturbance

1.5

9.5

273

1839

N06AX11

ATC

mirtazapine; oral

1.3

9.5

869

7134

M01AC06

ATC

meloxicam; systemic, rectal

1.3

9.5

960

7988

H00.00

ICD-10 Finland

Hordeolum

2.0

9.4

489

R04.2

ICD-10 Finland

Haemoptysis

2.0

9.4

101

517

R83

ICPC

Respiratory infection other

1.4

9.4

514

3909

N30.0

ICD-10 Finland

Acute cystitis

1.4

9.4

408

2983

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

9.4

150

872

ZX108

NOMESCO Finland

Inhalation

3.9

9.4

C08CA01

ATC

amlodipine; oral

1.3

9.4

1105

9372

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.5

9.4

335

2362

WX290

NOMESCO Finland

Other blockage of nerve

1.3

9.4

1065

8992

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

9.3

175

1065

WVA20

NOMESCO Finland

Medicine administration

2.2

9.3

325

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.7

9.3

154

905

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

9.3

250

1661

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

9.3

164

982

H13

ICPC

Plugged feeling ear

1.4

9.2

530

4061

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.6

9.2

193

1208

K84

ICPC

Heart disease other

2.1

9.2

412

E000006, ,

ATC

1.7

9.2

168

1015

C08DA01

ATC

verapamil; systemic

1.9

9.2

121

664

B01AF01

ATC

rivaroxaban; oral

1.4

9.2

372

2686

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

9.1

587

4577

S01AA01

ATC

chloramphenicol; ophthalmic

1.9

9.1

117

636

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.1

9.1

394

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

9.1

551

4260

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

9.1

726

5846

D07AD01

ATC

clobetasol; topical

1.4

9.1

418

3089

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

9.0

209

1340

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.5

9.0

229

S15

ICPC

Foreign body in skin

1.7

9.0

170

1035

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

9.0

348

2489

H93.1

ICD-10 Finland

Tinnitus

1.7

9.0

175

1074

H02.3

ICD-10 Finland

Blepharochalasis

1.6

9.0

184

1144

C03DA01

ATC

spironolactone; oral

1.5

9.0

335

2380

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

9.0

164

990

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

9.0

164

990

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.1

9.0

376

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.5

9.0

224

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.8

9.0

J01FA15

ATC

telithromycin; oral

1.6

8.9

237

1569

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.3

8.9

305

H02

ICPC

Hearing complaint

1.4

8.9

388

2837

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

8.9

685

5484

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.5

8.9

207

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

8.9

645

5121

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

8.9

171

1048

SPAT1053

SPAT

Memory test

1.4

8.8

427

3179

H92.0

ICD-10 Finland

Otalgia

1.8

8.8

132

753

SPAT1285

SPAT

Provision of consultation response

1.7

8.8

144

843

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

8.8

654

5207

S01EC03

ATC

dorzolamide; ophthalmic

2.7

8.8

173

U02

ICPC

Urinary frequency/urgency

1.4

8.8

358

2586

S22.3

ICD-10 Finland

Fracture of rib

1.6

8.8

190

1200

M01AB05

ATC

diclofenac; systemic, rectal

1.3

8.7

1753

15792

H40.9

ICD-10 Finland

Glaucoma, unspecified

2.4

8.7

245

A03FA02

ATC

cisapride; oral, rectal

1.6

8.7

199

1272

R06.2

ICD-10 Finland

Wheezing

1.9

8.7

112

610

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

8.7

145

854

QXB99, ,

SPAT

2.3

8.7

283

R06.4

ICD-10 Finland

Hyperventilation

2.8

8.7

146

R5120

NOMESCO Finland

Preparation of an aid

2.0

8.7

435

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

8.7

208

1346

M79.7

ICD-10 Finland

Fibromyalgia

2.1

8.6

355

M75.8

ICD-10 Finland

Other shoulder lesions

2.0

8.6

484

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

3.1

8.6

109

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

8.6

234

1557

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.6

8.6

184

1157

J05AB11

ATC

valaciclovir; oral

1.4

8.6

350

2527

R13

ICD-10 Finland

Dysphagia

1.6

8.6

187

1181

M35.7

ICD-10 Finland

Hypermobility syndrome

3.3

8.6

A07EA06

ATC

budesonide; oral, local oral

2.0

8.6

430

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

8.6

206

1333

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

8.6

106

570

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.6

8.6

176

1096

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.1

8.6

403

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

8.6

622

4934

VALMI, ,

NOMESCO Finland

1.3

8.6

553

4312

XCC00

NOMESCO Finland

Investigative irrigation of lacrimal passages

2.9

8.5

131

R06AX26

ATC

fexofenadine; oral

1.7

8.5

138

806

S12

ICPC

Insect bite/sting

1.6

8.5

222

1464

R01AC01

ATC

cromoglicic acid; nasal

2.3

8.5

292

R35

ICD-10 Finland

Polyuria

1.6

8.5

183

1153

T74.1

ICD-10 Finland

Physical abuse

3.0

8.5

126

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

8.5

348

2517

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

8.5

146

868

WX892

NOMESCO Finland

Monitored bed care

1.6

8.5

204

1321

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

8.5

192

1226

M43.1

ICD-10 Finland

Spondylolisthesis

1.9

8.4

106

573

A01AB09

ATC

miconazole; local oral

1.6

8.4

221

1459

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.7

8.4

H02AB09

ATC

hydrocortisone; systemic

2.3

8.4

287

H3601, E103,

ICD-10 Finland

3.9

8.4

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

8.4

215

1412

S21

ICPC

Skin texture symptom/complaint

1.4

8.4

365

2667

R06AX22

ATC

ebastine; oral

1.4

8.4

358

2607

R09

ICPC

Sinus symptom/complaint

1.6

8.4

176

1102

L16

ICPC

Ankle symptom/complaint

1.5

8.4

276

1913

M01AX05

ATC

glucosamine; oral

1.3

8.4

556

4351

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.3

8.4

C01BD01

ATC

amiodarone; systemic

2.0

8.4

420

L86

ICPC

Back syndrome with radiating pain

1.7

8.4

154

932

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

8.4

495

3807

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

8.4

195

1253

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

2.8

8.4

138

H33.3

ICD-10 Finland

Retinal breaks without detachment

1.9

8.4

518

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

8.4

257

1757

Z94.7

ICD-10 Finland

Corneal transplant status

6.7

8.3

R49.01

ICD-10 Finland

Functional dysphonia

2.1

8.3

387

D06BX01

ATC

metronidazole; topical

1.5

8.3

257

1758

H3601, H113,

ICD-10 Finland

+∞

8.3

M01AH01

ATC

celecoxib; oral

1.4

8.3

467

3562

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.9

8.3

101

540

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

8.3

121

685

A10AC01

ATC

insulin (human); parenteral

1.6

8.3

192

1232

SPAT1216

SPAT

Assessment of functional ability

1.4

8.3

435

3283

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

8.3

353

2572

M01AB55

ATC

diclofenac, combinations; oral

1.6

8.3

177

1115

D07AA02

ATC

hydrocortisone; topical

1.5

8.3

304

2155

K01

ICPC

Heart pain

2.7

8.2

156

R4180

NOMESCO Finland

Podiatric therapy

2.7

8.2

156

SPAT1360

SPAT

Extensive global examination

1.6

8.2

184

1171

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

8.2

185

1180

D11

ICPC

Diarrhoea

1.5

8.2

255

1748

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.7

8.2

SPAT1009

SPAT

Measurement of intraocular pressure

2.7

8.2

157

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.1

8.1

357

S01AX11

ATC

[U] ofloxacin

2.0

8.1

418

XG410

NOMESCO Finland

Flow-volume spirometry

1.9

8.1

105

573

R29

ICPC

Respiratory symptom/complaint other

1.6

8.1

165

1025

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

8.1

309

2204

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.8

8.1

110

610

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

8.1

1000

8491

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.2

8.1

292

XQ802

NOMESCO Finland

Epicutan test

2.0

8.1

447

WZC00, ,

SPAT

1.5

8.1

246

1679

H40.6

ICD-10 Finland

Glaucoma secondary to drugs

17.2

8.1

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

3.2

8.1

N64.4

ICD-10 Finland

Mastodynia

2.2

8.0

280

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

8.0

211

1394

S06

ICPC

Rash localized

1.7

8.0

147

889

Z3226

NOMESCO Finland

Physiotherapist

1.4

8.0

465

3564

H20

ICD-10 Finland

Iridocyclitis

6.3

8.0

C07AB02

ATC

metoprolol; systemic

1.3

8.0

556

4380

S01KA02

ATC

hypromellose; ophthalmic

2.6

8.0

182

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.6

8.0

165

1030

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

8.0

294

2084

R25.2

ICD-10 Finland

Cramp and spasm

2.2

8.0

294

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.9

8.0

104

570

Angiography of the heart and coronary arteries

1.6

8.0

172

1086

SCA02

NOMESCO Finland

Preventive oral health care

1.5

8.0

213

1414

N05CF01

ATC

zopiclone; oral

1.3

7.9

849

7082

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

3.2

7.9

A97

ICPC

No disease

1.4

7.9

448

3420

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.6

7.9

171

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.0

7.9

115

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

7.9

257

1777

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

7.9

950

8036

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.8

7.9

113

637

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.1

7.9

328

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

7.9

106

586

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

7.9

362

2670

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.7

7.9

130

764

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.7

7.9

153

940

R4180, ,

SPAT

3.0

7.9

110

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

7.9

224

1507

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

7.9

173

1097

ZXC50

NOMESCO Finland

Cryotherapy

1.9

7.9

508

H10.2

ICD-10 Finland

Other acute conjunctivitis

3.1

7.8

105

N05BA04

ATC

oxazepam; oral

1.3

7.8

644

5191

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

7.8

343

2510

S02.40

ICD-10 Finland

Fracture of malar and maxillary bones, closed

3.0

7.8

116

R01AD11

ATC

triamcinolone; nasal

1.6

7.8

200

1315

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.0

7.8

418

A10AB05

ATC

insulin aspart; parenteral

1.6

7.8

193

1260

D07AB08

ATC

desonide; topical

1.5

7.8

245

1685

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.3

7.7

259

J01CA08

ATC

pivmecillinam; oral

1.3

7.7

999

8517

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.2

7.7

298

XA402

NOMESCO Finland

ENMG

2.2

7.7

298

H20.8

ICD-10 Finland

Other iridocyclitis

4.3

7.7

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.2

7.7

286

XF640, ,

NOMESCO Finland

2.0

7.7

400

K05

ICPC

Irregular heartbeat other

1.9

7.7

491

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.0

7.6

414

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.7

7.6

145

886

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

7.6

127

749

R55

ICD-10 Finland

Syncope and collapse

1.4

7.6

289

2060

C10AA01

ATC

simvastatin; oral

1.2

7.6

1223

10683

R01AD05

ATC

budesonide; nasal

1.6

7.6

166

1051

SPAT1252

SPAT

Overall medication plan or its review

1.6

7.6

185

1202

H53.2

ICD-10 Finland

Diplopia

1.9

7.6

464

L04AA13

ATC

[U] leflunomide

2.2

7.5

301

H10

ICD-10 Finland

Conjunctivitis

1.7

7.5

139

843

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.5

7.5

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

2.6

7.5

158

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.9

7.5

494

L13

ICPC

Hip symptom/complaint

1.3

7.5

489

3812

H05AA02

ATC

teriparatide; parenteral

3.8

7.5

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

7.5

282

2006

H66.9

ICD-10 Finland

Otitis media, unspecified

1.7

7.5

121

707

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.7

7.5

141

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

3.0

7.5

108

S94

ICPC

Ingrowing nail

2.5

7.5

188

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

7.5

248

1722

UDM02

NOMESCO Finland

Sinoscopy

2.2

7.5

263

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.7

7.5

130

776

G04CA02

ATC

tamsulosin; oral

1.3

7.5

615

4957

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

7.4

112

642

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

7.4

153

955

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.9

7.4

475

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.9

7.4

475

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.3

7.4

245

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.8

7.4

110

628

S51.0

ICD-10 Finland

Open wound of elbow

2.8

7.4

131

S01GX04

ATC

nedocromil; ophthalmic

3.3

7.4

GD1AA, ,

SPAT

1.5

7.4

229

1570

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

7.4

182

1187

CBB30

NOMESCO Finland

Excision of lesion of eyelid

1.9

7.4

434

H81.3

ICD-10 Finland

Other peripheral vertigo

2.0

7.4

358

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.6

7.3

168

1076

R06.5

ICD-10 Finland

Mouth breathing

1.5

7.3

206

1382

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

7.3

365

CBA10

NOMESCO Finland

Biopsy of eyelid

3.0

7.3

104

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

7.3

525

4149

K29

ICPC

Cardiovascular sympt/complt other

1.7

7.3

121

712

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.1

7.3

298

SPAT1058

SPAT

PEF monitoring instruction

1.5

7.3

207

1391

L04AB04

ATC

adalimumab; parenteral

2.3

7.3

215

N02BF02

ATC

pregabalin; oral

1.7

7.3

138

843

TCG10

NOMESCO Finland

Removal of sutures from cornea

4.2

7.3

C07AA07

ATC

sotalol; systemic

1.8

7.3

100

558

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.2

7.3

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

7.2

264

1868

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

2.0

7.2

367

S08

ICPC

Skin colour change

1.7

7.2

141

868

R12

ICD-10 Finland

Heartburn

1.6

7.2

185

1217

A12AA04

ATC

calcium carbonate; oral

2.4

7.2

198

F79

ICPC

Injury eye other

7.3

7.2

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.0

7.2

341

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.7

7.2

119

702

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.4

7.1

326

2402

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

7.1

108

620

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.7

7.1

134

817

M15

ICD-10 Finland

Polyarthrosis

1.6

7.1

142

879

A99

ICPC

Disease/condition unspecnature/site

1.5

7.1

237

1647

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

7.1

181

1188

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.1

7.1

J01DC02

ATC

cefuroxime; systemic

1.7

7.1

121

718

B02.9

ICD-10 Finland

Zoster without complication

1.6

7.1

175

1140

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.1

7.1

295

S09

ICPC

Infected finger/toe

1.9

7.1

425

L95

ICPC

Osteoporosis

1.8

7.1

106

606

G04CB01

ATC

finasteride; oral

1.4

7.1

282

2027

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

7.1

555

4439

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

7.1

566

4539

H00.1

ICD-10 Finland

Chalazion

1.9

7.1

461

I49.1

ICD-10 Finland

Atrial premature depolarization

1.8

7.1

555

R03BC03

ATC

nedocromil; inhalant

1.6

7.1

159

1014

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

7.1

351

2623

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

5.6

7.1

SPAT1131

SPAT

Colonoscopy

1.9

7.0

462

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

1.9

7.0

434

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

7.0

283

2040

M04AA01

ATC

allopurinol; systemic

1.4

7.0

354

2652

L88

ICPC

Rheumatoid/seropositive arthritis

1.8

7.0

100

564

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

7.0

165

1064

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

7.0

334

2479

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.5

7.0

176

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

7.0

204

1381

H26.02

ICD-10 Finland

Presenil cataract

2.0

7.0

338

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

7.0

106

610

N06AB10

ATC

escitalopram; oral

1.3

7.0

425

3281

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

2.1

7.0

318

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

1.8

6.9

522

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

1.9

6.9

401

J01DA06

ATC

[U] cefuroxime

1.4

6.9

333

2477

P03

ICPC

Feeling depressed

1.6

6.9

175

1149

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.1

6.9

R75

ICPC

Sinusitis acute/chronic

1.8

6.9

103

590

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.7

6.9

109

635

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.6

6.8

140

873

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

6.8

206

1404

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

6.8

110

644

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.1

6.8

TQW40, ,

SPAT

1.5

6.8

181

1201

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

2.4

6.8

197

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.4

6.8

323

2398

D22.3

ICD-10 Finland

Melanocytic naevi of other and unspecified parts of face

2.1

6.8

268

L10

ICPC

Elbow symptom/complaint

1.7

6.8

109

638

T14.0

ICD-10 Finland

Superficial injury of unspecified body region

2.5

6.8

167

J04.0

ICD-10 Finland

Acute laryngitis

2.0

6.8

349

Z01.7

ICD-10 Finland

Laboratory examination

1.4

6.7

348

2617

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

6.7

563

4540

SPAT1057

SPAT

Peak expiratory flow measurement

2.1

6.7

295

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

6.7

209

1434

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.1

6.7

309

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

6.7

521

S92.3

ICD-10 Finland

Fracture of metatarsal bone

1.9

6.7

413

H33.5

ICD-10 Finland

Other retinal detachments

3.2

6.7

H35.36

ICD-10 Finland

Macular cyst

3.2

6.7

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

6.7

306

2256

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.4

6.7

174

A11CC03

ATC

alfacalcidol; systemic

2.0

6.7

330

CFD10

NOMESCO Finland

Repair of conjunctiva

22.6

6.7

130

Kela drug reimbursment

Malignant tumour

0.6

6.7

102

1702

A10

ICPC

Bleeding/haemorrhage NOS

3.0

6.6

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

2.7

6.6

133

HMAK, ,

NOMESCO Finland

1.4

6.6

251

1789

H30.2

ICD-10 Finland

Posterior cyclitis

6.4

6.6

S05.8

ICD-10 Finland

Other injuries of eye and orbit

6.4

6.6

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

6.6

113

672

I45.9

ICD-10 Finland

Conduction disorder, unspecified

2.9

6.6

105

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.0

6.6

345

L04

ICPC

Chest symptom/complaint

1.6

6.6

151

969

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

6.6

131

812

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.4

6.5

246

1751

J45.8

ICD-10 Finland

Mixed asthma

1.9

6.5

388

SPAT1240

SPAT

Therapeutic discussion

1.5

6.5

205

1409

H02.1

ICD-10 Finland

Ectropion of eyelid

3.0

6.5

L84

ICD-10 Finland

Corns and callosities

1.8

6.5

504

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.3

6.5

214

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

2.2

6.5

227

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.8

6.5

490

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.7

6.5

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

6.5

174

1158

R52.2

ICD-10 Finland

Other chronic pain

1.8

6.5

483

M05BX04

ATC

denosumab; parenteral

1.5

6.5

171

1134

C09AA05

ATC

ramipril; oral

1.3

6.5

688

5716

R00.8

ICD-10 Finland

Other and unspecified abnormalities of heart beat

2.6

6.4

141

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.6

6.4

159

1038

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

6.4

433

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

6.4

498

3974

CD2S4

NOMESCO Finland

Photography of eye

3.9

6.4

G03DB01

ATC

dydrogesterone; oral

1.4

6.4

239

1698

B01AB04

ATC

dalteparin; parenteral

1.6

6.4

132

825

QCB10, ,

SPAT

3.4

6.4

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.3

6.4

209

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

6.4

1721

15744

N06AA09

ATC

amitriptyline; systemic

1.4

6.4

240

1709

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.5

6.4

166

1097

R4110

NOMESCO Finland

Physiotherapy

1.3

6.4

704

5873

SAA04

NOMESCO Finland

Special examination of mouth

1.7

6.4

120

734

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

2.5

6.3

148

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

6.3

136

859

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

1.9

6.3

414

K03.66

ICD-10 Finland

Tooth plaque

1.5

6.3

169

1123

SPAT1101

SPAT

Orthostatic test

1.7

6.3

119

727

C02AC05

ATC

moxonidine; oral

1.6

6.3

127

789

H3603, E113,

ICD-10 Finland

2.9

6.3

D68.9

ICD-10 Finland

Coagulation defect, unspecified

6.0

6.3

315

Kela drug reimbursment

Clopidogrel

2.6

6.3

131

PAW37

NOMESCO Finland

Biopsy of temporal artery

3.2

6.3

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

6.3

151

980

S82

ICPC

Naevus/mole

1.4

6.3

313

2341

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

6.3

1013

8806

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

2.5

6.3

155

K04.08

ICD-10 Finland

Other specified pulpit

1.6

6.3

145

933

H82

ICPC

Vertiginous syndrome

2.2

6.3

237

H3603, H113,

ICD-10 Finland

+∞

6.3

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

6.2

334

2527

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

6.2

172

1152

WX722

NOMESCO Finland

PEEP

1.7

6.2

116

708

WX199

NOMESCO Finland

Other local analgesia

1.8

6.2

497

K62.3

ICD-10 Finland

Rectal prolapse

2.5

6.2

144

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.5

6.2

150

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

6.2

155

1016

P20

ICPC

Memory disturbance

1.3

6.2

387

2998

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

6.2

110

663

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.2

6.2

232

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

1.8

6.2

498

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

6.2

276

2028

J01AA04

ATC

lymecycline; systemic

1.4

6.2

262

1908

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.9

6.1

397

H21.0

ICD-10 Finland

Hyphaema

5.7

6.1

H10.8

ICD-10 Finland

Other conjunctivitis

3.4

6.1

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.0

6.1

334

CS494

NOMESCO Finland

Other visual field testing

1.9

6.1

362

SPAT1307

SPAT

Psychosocial counselling and guidance

1.7

6.1

566

ZY010, ,

SPAT

2.5

6.1

151

R1250, ,

SPAT

2.3

6.1

188

A29

ICPC

General symptom/complaint other

1.4

6.1

315

2369

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

6.1

233

1665

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.0

6.1

321

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

6.1

342

D01AE16

ATC

amorolfine; topical

1.4

6.1

301

2250

U01

ICPC

Dysuria/painful urination

1.5

6.1

178

1208

G04CA01

ATC

alfuzosin; oral

1.4

6.0

309

2320

F28

ICPC

Limited function/disability (F)

3.6

6.0

K24

ICPC

Fear of heart disease

1.9

6.0

378

L50.9

ICD-10 Finland

Urticaria, unspecified

1.9

6.0

421

M05BA04

ATC

alendronic acid; oral

1.4

6.0

237

1702

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

6.0

123

768

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

6.0

357

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.1

6.0

241

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022217) INR in Platelet poor plasma by Coagulation assay

1734

12603

1.88

60.88

27.8

16.5

1.37

1.31

inr

1.63

557

3598

(3013115) Eosinophils [#/volume] in Blood

1767

13037

1.85

57.88

7.9

6.0

0.19

e9/l

0.96

1586

11327

(3006315) Basophils [#/volume] in Blood

1718

12591

1.84

57.23

7.6

5.7

0.04

e9/l

0.57

1525

10810

(3001604) Monocytes [#/volume] in Blood

1710

12559

1.83

56.09

7.6

5.7

0.59

0.60

e9/l

0.99

1520

10783

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1214

8065

1.84

55.03

2.5

2.1

158.60

228.26

u/l

3.10

1147

7542

(3019198) Lymphocytes [#/volume] in Blood

1735

12868

1.82

54.38

7.6

5.8

1.94

1.92

e9/l

0.07

1568

11300

(3013707) Erythrocyte sedimentation rate by Westergren method

2307

18747

1.97

53.61

6.2

4.1

12.29

13.25

mm/h

2.56

2151

17265

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1440

10139

1.80

53.37

5.1

3.8

84.45

100.29

ng/l

0.10

1098

7402

(40760892) CBC W Ordered Manual Differential panel - Blood

1615

11858

1.78

51.03

8.4

6.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1434

10250

1.76

49.05

3.6

2.8

134.71

141.77

ug/l

0.52

1328

9362

(3019069) Monocytes/100 leukocytes in Blood

1594

11847

1.73

46.53

8.2

6.4

8.59

8.73

1.06

1494

11055

(3006504) Eosinophils/100 leukocytes in Blood

1585

11790

1.72

45.87

7.7

6.0

2.75

2.84

0.88

1485

10993

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2376

19920

1.90

44.62

10.1

7.6

77.78

79.97

u/l

1.27

2253

18745

(3013650) Neutrophils [#/volume] in Blood by Automated count

1877

14716

1.73

44.02

10.2

9.0

4.09

4.16

e9/l

0.64

1679

12790

(3013826) Glucose [Moles/volume] in Serum or Plasma

1932

15319

1.72

42.96

6.7

4.7

6.74

6.78

mmol/l

0.41

1846

14417

(3002030) Lymphocytes/100 leukocytes in Blood

1605

12120

1.69

42.71

8.0

6.2

27.06

27.24

0.28

1504

11341

(3018010) Neutrophils/100 leukocytes in Blood

1583

11936

1.68

42.14

7.6

5.9

57.95

57.62

0.51

1482

11150

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1168

8131

1.71

41.92

3.0

2.6

60.46

69.93

u/l

0.45

1085

7488

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2782

24875

2.47

41.35

22.4

15.3

21.43

24.84

mg/l

6.87

2377

19903

(3022096) Basophils/100 leukocytes in Blood

1525

11454

1.67

40.63

7.8

6.1

0.67

0.02

1424

10656

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1723

13366

1.67

40.42

9.3

6.9

1.21

mmol/l

0.31

1449

11341

(3037467) Urinalysis macro (dipstick) panel - Urine

2118

17412

1.72

39.31

6.0

4.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

832

5407

1.74

37.42

2.4

1.8

1.29

1.36

mg/l

0.20

617

4204

(3037522) Nuclear Ab [Titer] in Serum

541

3093

1.91

37.05

1.4

1.3

547.32

532.08

titre

0.07

123

669

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1139

8130

1.64

35.59

4.1

3.1

1400.68

1550.13

ng/l

0.67

992

7013

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1404

10562

1.61

35.36

2.7

2.2

79.72

78.50

nmol/l

0.85

1245

9351

(3031040) Bacteria [#/volume] in Urine by Automated count

2041

16820

1.66

35.33

6.2

4.6

749.67

2256.27

e6/l

1.31

256

(3019550) Sodium [Moles/volume] in Serum or Plasma

2845

26036

2.55

34.15

25.2

17.9

139.77

139.67

mmol/l

1.38

2800

25374

(3023103) Potassium [Moles/volume] in Serum or Plasma

2849

26100

2.57

33.92

25.4

18.1

3.99

3.98

mmol/l

1.09

2801

25399

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

965

6668

1.66

33.89

2.6

2.3

3.16

3.02

mg/l

0.97

855

5660

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2591

22921

1.91

33.63

5.9

4.8

1.95

2.05

mu/l

0.60

2360

20759

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

650

4042

1.77

33.59

1.3

33.94

36.54

iu/ml

0.18

217

1307

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2226

18963

1.66

31.73

4.8

4.0

14.97

14.92

pmol/l

0.41

2013

17048

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1706

13667

1.57

31.29

7.5

6.3

11.78

11.69

umol/l

0.11

1630

12966

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1548

12132

1.56

31.28

8.2

6.1

1.21

mmol/l

0.12

1397

11033

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

228

1030

2.31

28.94

2.0

1.8

37.50

38.98

u/l

0.58

206

900

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1701

13764

1.54

28.69

2.9

2.6

—

(3002582) Erythrocytes [#/volume] in Urine

1081

7920

1.57

28.67

4.2

3.3

70.23

78.42

e6/l

0.10

904

6131

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2859

26493

2.43

28.53

25.1

18.0

83.10

79.08

umol/l

5.40

2859

26483

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2694

24437

1.93

28.15

5.4

4.8

6.00

6.01

mmol/l

0.14

2432

22067

(3018677) aPTT in Platelet poor plasma by Coagulation assay

640

4147

1.69

27.91

2.6

2.1

30.34

29.93

0.88

619

4024

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2855

26496

2.37

27.40

14.9

10.8

25.49

25.67

u/l

0.21

2764

25470

(40768797) Stomach Pathology biopsy report

563

3548

1.72

27.13

1.3

1.2

—

(3018095) Leukocytes [#/volume] in Urine

1206

9137

1.53

27.07

4.8

3.7

50.49

109.70

e6/l

4.16

956

6560

(3000850) Epithelial cells [#/volume] in Urine

801

5539

1.61

26.86

3.3

2.6

3.96

5.48

e6/l

4.73

741

4980

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2614

23583

1.80

26.47

19.7

14.4

75.58

77.41

ml/min/173m2

4.20

2247

19503

(3019309) Folate [Moles/volume] in Red Blood Cells

758

5190

1.61

26.41

1.9

1.8

1271.82

1181.68

nmol/l

1.65

569

3876

(3023368) Bacteria identified in Blood by Culture

1017

7457

1.55

26.33

4.7

4.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

938

6779

1.56

25.81

3.6

2.7

3142.82

5545.39

umol/l

1.28

807

5861

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

667

4466

1.63

25.30

2.0

1.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2692

24583

1.86

25.09

5.4

4.6

4.56

4.62

mmol/l

1.92

2482

22564

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2674

24374

1.83

24.99

5.3

4.5

1.47

mmol/l

0.09

2448

22207

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1386

10965

1.49

24.46

2.3

2.0

97.19

94.44

pmol/l

1.10

693

5606

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2598

23532

1.74

24.18

4.7

4.1

1.30

mmol/l

0.10

2355

21262

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2578

23309

1.72

24.05

7.1

6.0

40.45

40.26

mmol/mol

0.46

2383

21405

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2730

25113

1.89

23.81

5.9

5.1

2.65

2.70

mmol/l

2.48

2499

22901

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

586

3851

1.65

23.78

1.3

1.2

12.06

13.29

u/ml

0.15

217

1459

(3007461) Platelets [#/volume] in Blood

2911

27432

2.61

23.75

32.3

22.6

239.55

248.29

e9/l

10.90

2862

26670

(3024731) MCV [Entitic volume]

2911

27443

2.60

23.53

32.2

22.5

91.47

91.35

0.71

2878

26997

(3035941) MCH [Entitic mass]

2911

27444

2.60

23.51

32.2

22.4

30.37

0.04

2878

26995

(3009542) Hematocrit [Volume Fraction] of Blood

2909

27418

2.58

23.48

32.6

22.6

39.79

0.02

2735

25445

(3026361) Erythrocytes [#/volume] in Blood

2911

27446

2.60

23.47

32.3

22.5

4.42

4.45

e12/l

3.09

2858

26588

(3010813) Leukocytes [#/volume] in Blood

2911

27446

2.60

23.47

32.3

22.5

6.70

6.78

e9/l

0.82

2858

26583

(3000963) Hemoglobin [Mass/volume] in Blood

2911

27453

2.59

23.33

32.5

22.7

133.19

134.28

g/l

3.67

2876

27009

(40761511) CBC panel - Blood by Automated count

2775

25699

1.96

23.18

21.0

14.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

725

5059

1.57

22.81

1.3

1.2

2.26

1.56

u/ml

0.43

207

1309

(3022948) Iron [Moles/volume] in Serum or Plasma

620

4174

1.61

22.70

3.4

2.5

13.00

12.73

umol/l

0.41

587

3880

(3007164) IgA [Mass/volume] in Serum or Plasma

651

4439

1.59

22.59

1.5

2.39

2.54

g/l

1.21

381

2626

(3036481) Cortisol [Moles/volume] in Serum or Plasma

380

2250

1.79

22.48

2.4

2.1

342.03

372.85

nmol/l

2.64

349

2050

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

490

3121

1.68

22.31

1.9

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

972

7264

1.50

22.13

4.1

3.2

0.37

0.50

e6/l

0.92

799

5582

(3018418) pH of Serum or Plasma

1042

7921

1.48

21.71

5.4

4.1

7.40

0.09

219

1496

(3009445) Proteinase 3 Ab [Units/volume] in Serum

216

1071

2.09

21.70

1.6

26.99

17.83

u/ml

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

576

3847

1.61

21.69

3.4

2.5

2.33

2.29

g/l

1.06

545

3550

(3048689) Calprotectin [Mass/mass] in Stool

435

2726

1.70

20.97

2.3

2.1

137.29

143.44

ug/g

0.13

339

2131

(3021960) Folate [Moles/volume] in Serum or Plasma

865

6369

1.50

20.94

1.7

1.6

21.21

20.25

nmol/l

0.85

727

5386

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

545

3626

1.61

20.76

3.6

2.6

22.49

22.54

0.03

473

3070

(3021589) Normoblasts [#/volume] in Blood

1374

11084

1.44

20.65

12.7

9.9

0.00

e9/l

0.60

1187

9044

(3012095) Magnesium [Moles/volume] in Serum or Plasma

631

4354

1.57

20.57

4.5

3.3

0.81

0.82

mmol/l

0.08

598

4065

(3026008) Bacteria identified in Urine by Culture

1075

8288

1.46

20.55

3.8

3.3

—

(3009261) Glucose [Presence] in Urine by Test strip

1510

12421

1.43

20.24

5.2

3.8

0.00

estimate

1.08

318

2215

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

480

3118

1.64

20.09

1.9

1.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

1493

12267

1.43

20.07

6.7

5.1

0.00

estimate

0.50

328

2277

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

349

2085

1.76

19.92

4.9

4.0

104.27

91.73

ng/l

1.43

296

1778

(3003458) Phosphate [Moles/volume] in Serum or Plasma

531

3549

1.60

19.76

8.6

5.9

1.03

1.04

mmol/l

0.35

503

3286

(36304419) Bacteria [Presence] in Urine

931

7023

1.47

19.74

4.1

3.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

177

846

2.16

19.54

1.3

1.2

0.48

1.25

u/ml

0.92

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

157

716

2.26

19.46

3.5

2.5

3.52

3.59

g/l

0.22

147

674

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

142

621

2.35

19.41

2.0

10.81

12.10

mg/l

0.95

131

563

(40768804) Tissue Pathology biopsy report

1277

10249

1.43

19.30

2.3

2.1

—

(3042936) Bacteria identified in Isolate by Culture

550

3729

1.58

19.22

2.4

2.0

—

(3035350) Ketones [Presence] in Urine by Test strip

1489

12291

1.42

19.15

5.1

3.8

0.00

estimate

0.99

353

2441

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1040

8076

1.44

18.69

4.4

3.2

30.71

38.08

u/l

2.29

981

7649

(3029937) Albumin [Presence] in Urine by Test strip

887

6697

1.46

18.48

5.6

4.2

0.00

estimate

1.08

316

2177

(3007853) Bacteria identified in Skin by Aerobe culture

447

2909

1.63

18.47

2.1

1.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1399

11488

1.41

18.19

6.3

4.8

35.26

35.06

g/l

0.70

1304

10663

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

385

2428

1.67

17.97

3.0

2.4

8.87

7.26

ug/l

0.48

329

2123

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

712

5174

1.49

17.92

5.4

3.8

532.23

576.33

ng/l

0.05

592

4235

(3027945) Reticulocytes/100 erythrocytes in Blood

474

3157

1.59

17.75

3.2

2.5

1.88

1.79

0.88

422

2773

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1447

11988

1.40

17.67

2.9

2.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

778

5783

1.46

17.39

1.7

9698391.31

26803691.26

pmol/l

0.83

629

4783

(3023520) Reticulocytes [#/volume] in Blood

378

2394

1.66

17.33

3.3

2.6

72.17

69.48

e9/l

0.59

301

1829

(3036489) Thrombin time

183

929

2.03

17.24

2.9

2.1

22.20

21.65

0.32

162

828

(3017181) Myelocytes/100 leukocytes in Blood

352

2195

1.68

17.11

5.0

4.0

0.89

0.01

130

782

(3042733) HLA Ab [Presence] in Serum

5.12

16.93

5.4

4.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

627

4486

1.50

16.91

3.4

2.8

0.70

1.13

e6/l

4.92

421

2606

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1821

15745

1.39

16.87

3.9

3.1

49.70

52.29

u/l

0.65

1696

14461

(3015377) Calcium [Moles/volume] in Serum or Plasma

1132

9049

1.40

16.80

3.5

3.4

2.35

mmol/l

0.40

976

7907

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

483

3271

1.57

16.77

1.6

1.4

—

(3026782) Osmolality of Urine

719

5307

1.47

16.54

3.9

2.9

528.00

537.89

mosm/kgh2o

0.59

636

4562

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1165

9383

1.39

16.44

5.5

4.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

143

678

2.16

16.14

3.9

2.5

193.12

197.74

0.22

133

648

(3026250) Tacrolimus [Mass/volume] in Blood

4.27

15.96

37.1

30.1

7.53

7.33

ug/l

0.20

(3044640) Blood type and Crossmatch panel - Blood

1031

8165

1.40

15.96

2.9

2.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

323

2006

1.68

15.91

4.7

3.8

0.59

0.68

0.40

116

676

(3013512) EKG study

1000

7883

1.40

15.89

5.0

4.0

—

(3044889) 12 lead EKG panel

2038

18049

1.40

15.76

4.9

4.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

314

1941

1.69

15.73

1.9

1.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

247

1437

1.78

15.35

1.3

53.87

55.23

au/ml

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

266

1591

1.74

15.02

2.4

33.25

22.88

au/ml

0.49

108

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

164

851

1.98

14.55

1.6

96.00

328.10

titre

—

(40761535) Cells panel - Urine sediment

347

2246

1.62

14.49

4.9

3.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

327

2087

1.64

14.45

5.0

4.1

0.16

0.11

0.40

107

676

(3015736) pH of Urine

1194

9802

1.36

14.41

4.6

3.5

5.86

5.77

0.37

560

(3025941) Bacteria identified in Stool by Culture

226

1305

1.79

14.40

1.5

1.2

—

(3000494) Fungus identified in Specimen by Culture

429

2944

1.53

13.86

1.7

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

295

1855

1.65

13.81

3.0

2.8

9.87

10.60

g/l

2.20

266

1683

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

106

478

2.26

13.57

12.6

5.4

455.17

723.71

iu/ml

0.37

(3022145) Colonoscopy Study observation

414

2832

1.54

13.56

1.4

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

146

748

2.00

13.44

3.3

2.3

92.33

90.20

0.46

139

728

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

133

659

2.07

13.42

1.8

1.6

0.23

0.24

g/l

0.81

124

631

(3009343) pH of Capillary blood

275

1724

1.65

13.01

4.1

3.7

7.41

0.03

209

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

239

1445

1.71

12.96

3.5

3.3

4.41

4.44

pmol/l

0.13

202

1268

(3002385) Erythrocyte distribution width [Ratio]

2317

21215

1.39

12.94

25.5

18.2

14.89

15.15

1.41

2298

20819

(3002032) Base excess in Venous blood by calculation

377

2553

1.54

12.90

5.7

3.7

2.13

2.01

mmol/l

0.27

336

2138

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

135

683

2.02

12.88

1.8

1.5

1.16

1.17

g/l

0.17

128

653

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

568

4181

1.44

12.87

3.7

3.0

2.17

2.39

e6/l

0.23

361

2320

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

277

1750

1.64

12.71

4.2

3.7

5.08

5.14

kpa

0.53

259

1657

(40758558) Short blood count panel - Blood

822

6462

1.37

12.69

7.6

6.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

366

2479

1.54

12.50

12.9

7.5

11.01

10.30

mmol/l

1.13

349

2349

(3025159) Blasts/100 leukocytes in Blood

304

1974

1.60

12.48

5.0

4.1

0.08

0.39

0.83

564

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

138

713

1.98

12.43

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

376

2568

1.53

12.36

5.7

3.7

5.86

5.83

kpa

0.21

363

2491

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

206

2.85

12.22

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

215

2.78

11.87

2.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

442

3152

1.47

11.75

5.2

4.1

257.58

247.09

u/l

0.74

427

2962

(3005322) IgE [Units/volume] in Serum or Plasma

219

1332

1.69

11.62

1.4

1.3

174.72

192.08

u/ml

0.13

207

1224

(3041096) Erythrocytes [Presence] in Urine by Automated

807

6415

1.35

11.40

4.9

3.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

262

1678

1.61

11.37

5.0

3.1

127.78

127.74

g/l

0.01

251

1633

(3014111) Lactate [Moles/volume] in Serum or Plasma

346

2374

1.52

11.09

9.0

6.7

1.34

1.37

mmol/l

0.21

339

2326

(3033658) Prothrombin time (PT) actual/Normal

819

6550

1.34

11.05

5.4

4.0

84.22

88.27

3.65

796

6383

(3024354) Oxygen [Partial pressure] in Venous blood

314

2116

1.54

10.94

4.6

3.1

4.56

4.57

kpa

0.04

302

2047

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

258

1663

1.60

10.90

4.0

3.7

1.55

1.84

mmol/l

0.66

180

1234

(3008898) HLA-B27 [Presence]

123

648

1.94

10.51

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

212

2.67

10.51

1.6

1.3

6.61

7.07

g/l

0.40

149

(3024139) IgG subclass 3 [Mass/volume] in Serum

212

2.67

10.51

1.6

1.3

0.36

0.42

g/l

0.59

149

(3028192) IgG subclass 2 [Mass/volume] in Serum

212

2.67

10.51

1.6

1.3

2.86

2.91

g/l

0.08

149

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.43

10.39

1.2

2.0

—

(4062490) Immunoglobulin typing, IgG

214

2.65

10.33

1.6

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

323

2222

1.51

10.21

4.2

3.9

1.23

mmol/l

0.09

290

1937

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

126

676

1.90

10.21

2.1

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

783

6286

1.33

10.15

2.7

2.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

442

2.12

10.15

1.6

1.4

—

(3012516) Albumin [Mass/volume] in Urine

970

8030

1.31

10.08

3.9

3.2

450.90

348.53

mg/l

0.27

632

5107

(3009508) Creatinine [Moles/volume] in Urine

1002

8341

1.30

9.97

3.8

3.2

7.06

7.26

mmol/l

0.78

845

6995

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

488

2.04

9.84

3.1

3.5

57.18

57.49

0.08

488

(3016502) Oxygen saturation in Arterial blood

393

2835

1.44

9.76

8.8

7.4

95.43

95.54

0.12

375

2727

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

115

608

1.93

9.75

1.3

1.2

26.92

28.32

u/ml

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

164

970

1.73

9.66

3.6

3.0

0.31

0.34

u/ml

0.95

102

558

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

208

1313

1.63

9.58

2.2

1.7

1.49

1.54

g/l

0.33

185

1122

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

221

1416

1.60

9.58

2.5

2.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

343

2419

1.47

9.58

3.8

2.9

239.08

213.65

ng/l

0.44

315

2220

(3011985) Renin [Units/volume] in Plasma

328

2.26

9.52

2.0

1.4

100.72

52.12

mu/l

0.59

291

(3019150) Specific gravity of Urine by Refractometry

689

5474

1.33

9.51

5.4

4.2

1.02

kg/l

0.20

100

847

(36660697) Celiac disease serology panel - Serum

269

1813

1.53

9.35

1.2

—

(3049717) Cytology report of Urine Cyto stain

174

1057

1.69

9.31

2.7

2.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

160

951

1.72

9.27

2.8

2.2

226.53

750.63

ug/l

1.68

148

891

(3014148) Varicella zoster virus Ab [Titer] in Serum

215

2.54

9.21

1.1

—

(3017732) Neutrophils [#/volume] in Blood

258

1730

1.54

9.18

3.7

3.2

4.95

5.50

e9/l

0.27

186

1370

(3010838) Calcium [Moles/time] in 24 hour Urine

461

2.03

9.11

1.6

1.9

5.01

5.06

mmol/24h

0.04

386

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

122

673

1.85

9.10

1.5

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

828

6788

1.30

9.07

1.7

1.6

1.32

1.36

mmol/l

0.84

688

5653

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

157

937

1.71

8.98

3.3

2.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

133

757

1.79

8.97

1.5

1.4

251.24

278.78

ug/g

0.92

447

(3020682) Albumin/Creatinine [Ratio] in Urine

1005

8462

1.28

8.92

4.6

3.8

12.68

8.94

mg/mmol

1.20

631

5308

(3024471) HLA-A [Type]

3.61

8.83

1.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

142

828

1.75

8.82

1.4

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

393

2.09

8.76

1.5

1.4

107.63

116.69

u/ml

0.45

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

107

574

1.90

8.72

2.1

1.8

5.90

4.51

iu/l

0.45

186

(3028026) IgM [Mass/volume] in Serum or Plasma

225

1482

1.56

8.68

1.7

1.8

1.04

1.42

g/l

3.93

204

1337

(3024980) IgG subclass 4 [Mass/volume] in Serum

356

2.13

8.59

1.5

1.6

0.57

0.88

g/l

2.89

274

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

251

1700

1.52

8.54

1.7

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

216

1420

1.56

8.41

1.2

141.79

141.51

iu/ml

0.00

513

(3017143) Hepatitis C virus Ab [Presence] in Serum

327

2344

1.44

8.37

1.8

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

127

729

1.77

8.34

1.7

1.5

13.54

9.90

iu/ml

0.09

154

(3026389) Candida sp identified in Specimen by Organism specific culture

321

2.18

8.32

1.5

1.3

—

(3024932) HLA-DR beta [Type]

3.53

8.24

1.0

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

394

2928

1.40

8.23

3.9

2.8

6.61

8.82

umol/l

2.85

342

2555

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.22

8.21

10.9

7.0

6371.00

61.07

mg/l

0.49

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.92

8.14

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

3.25

8.07

1.5

2.1

22.26

104.95

ug/l

0.49

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

105

575

1.86

8.06

1.3

1.2

21.29

6.77

u/ml

—

106

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

181

1157

1.60

7.96

2.0

1.9

3.20

2.45

ug/l

0.22

162

1018

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

308

2.17

7.92

1.4

1.3

347.94

313.67

pmol/l

0.26

265

(3003396) Base excess in Arterial blood by calculation

418

3157

1.38

7.91

8.6

7.1

1.26

1.19

mmol/l

0.12

340

2494

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

416

2.00

7.90

1.3

1.2

42.71

46.82

u/ml

0.09

(3027273) Bicarbonate [Moles/volume] in Venous blood

205

1354

1.55

7.83

4.5

3.2

25.72

25.30

mmol/l

0.92

198

1312

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.79

7.79

1.1

1.0

—

(40768446) Kidney Pathology biopsy report

3.24

7.79

1.9

1.7

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

419

3176

1.37

7.75

8.6

7.1

5.03

5.11

kpa

1.06

396

3028

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

356

2630

1.40

7.69

1.8

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

112

637

1.79

7.62

1.8

1.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

418

3176

1.37

7.61

8.6

7.1

11.75

12.11

kpa

0.73

399

3027

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

478

1.91

7.60

1.2

3.71

2.55

u/ml

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

352

2601

1.40

7.59

9.5

7.9

119.33

120.83

g/l

0.69

341

2526

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

500

1.89

7.57

1.2

—

272.86

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

193

1268

1.56

7.56

4.7

2.6

1.29

1.21

0.49

193

1256

(3014765) Yersinia sp identified in Stool by Organism specific culture

121

706

1.74

7.55

1.4

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

408

3094

1.37

7.52

2.0

1.6

—

(3000991) Gas panel - Venous blood

307

2228

1.42

7.34

11.3

8.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1002

8589

1.25

7.31

5.7

5.2

2.54

3.24

ug/l

1.24

886

7670

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

297

2144

1.43

7.31

3.1

2.7

58.84

62.75

ml/min/173m2

0.91

125

890

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

109

624

1.77

7.27

1.8

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

119

699

1.73

7.26

1.4

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

268

2.19

7.16

1.2

1.3

57.23

50.48

u/ml

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

720

5956

1.27

7.08

4.8

3.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

120

712

1.71

7.07

1.4

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

187

1242

1.54

6.99

4.7

2.6

0.62

0.65

0.60

187

1232

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

231

1604

1.48

6.98

1.6

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

100

566

1.79

6.95

1.3

1.2

1.87

3.83

u/ml

—

(3019225) pH of Specimen

364

2746

1.37

6.92

5.2

4.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

525

1.82

6.83

1.9

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

115

683

1.71

6.77

1.8

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

420

1.90

6.70

1.7

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

420

1.90

6.70

1.7

1.5

—

(4200892) Spirometry reversibility

252

1796

1.44

6.66

1.5

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

366

1.96

6.59

8.2

6.5

12.62

11.98

mg/l

0.38

346

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

252

2.16

6.54

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

102

592

1.75

6.53

1.3

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

103

602

1.74

6.44

1.7

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

434

1.87

6.39

1.5

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

186

1259

1.51

6.39

2.1

1.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

371

1.94

6.35

5.6

2.7

720.33

401.85

u/ml

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

361

2769

1.34

6.16

4.0

3.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

299

2.03

6.15

1.7

1.5

64.52

62.49

0.15

186

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

404

1.88

6.14

1.4

1.2

348.77

270.60

u/ml

1.27

241

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.30

6.13

1.0

1.1

80.55

85.09

0.30

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.12

6.08

1.0

1.1

86.29

80.46

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

162

1077

1.53

6.07

1.4

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

538

1.75

6.05

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.89

6.04

3.4

2.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

100

591

1.72

6.03

1.3

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

458

1.81

6.00

1.7

1.4

—

(3021788) Differential panel - Synovial fluid

458

1.81

6.00

1.6

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.25

6.00

1.0

1.4

85.45

80.89

0.18

(3022313) Gas panel - Capillary blood

183

1252

1.49

5.99

4.4

3.9

—

(3023419) Bacteria identified in Sputum by Culture

415

1.85

5.98

3.9

2.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

172

1164

1.51

5.93

5.0

5.2

1.66

1.59

0.38

163

1085

(3000475) Leukocytes [#/volume] in Synovial fluid

104

625

1.69

5.91

1.6

1.7

10515.27

14716.83

e6/l

0.76

441

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

123

772

1.62

5.91

2.0

1.8

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

118

2.64

5.89

1.9

2.4

2761.55

1238.03

u/ml

0.53

118

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

201

1407

1.46

5.86

2.1

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

164

1103

1.51

5.83

1.1

1.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

433

1.82

5.83

1.3

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

231

2.14

5.82

1.7

1.5

27.39

28.92

0.11

148

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

199

2.23

5.79

1.5

1.3

—

(40768443) Skin Pathology biopsy report

165

1113

1.51

5.79

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

107

652

1.66

5.78

2.0

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

807

6900

1.23

5.77

4.9

4.4

21.88

21.75

0.08

408

3512

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

365

1.88

5.66

1.7

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

609

5058

1.26

5.66

2.9

3.1

2.45

2.46

mmol/l

1.44

529

4445

(3007930) Methemoglobin/Hemoglobin.total in Blood

169

1152

1.49

5.64

5.0

5.3

0.86

0.88

0.14

160

1075

(3027456) Digoxin [Moles/volume] in Serum or Plasma

102

619

1.67

5.60

3.6

3.1

0.76

0.81

nmol/l

0.90

477

(3009871) Measles virus Ab [Titer] in Serum

3.20

5.59

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

152

2.38

5.55

1.1

1.2

0.11

1.73

u/ml

1.75

(3023183) Ammonium ion [Moles/volume] in Plasma

575

1.69

5.54

3.6

2.8

33.13

36.01

umol/l

0.54

516

(3021879) Hepatitis B virus core Ab [Presence] in Serum

209

1491

1.43

5.53

1.5

1.4

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

284

1.99

5.51

1.7

1.9

—

2.60

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

384

1.84

5.46

1.8

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

186

2.22

5.38

1.2

60.00

126.76

titre

—

(3045414) Leukocytes [Presence] in Urine

168

1157

1.48

5.35

2.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

305

2335

1.34

5.27

3.2

2.5

81.75

59.30

u/l

0.19

265

2000

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

310

1.92

5.26

2.0

1.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

238

1753

1.39

5.26

8.0

6.9

24.70

24.64

mmol/l

0.08

225

1663

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

479

1.73

5.20

1.9

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

225

1645

1.40

5.19

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

376

1.83

5.19

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.89

5.19

1.0

1.1

1699.30

1582.79

miu/ml

0.20

(3052851) Hemolysis interference index of Serum or Plasma

122

790

1.57

5.18

3.7

3.3

—

(3019060) Gas panel - Arterial blood

250

1864

1.37

5.13

5.2

4.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

128

2.44

5.04

3.8

3.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

395

1.79

5.01

1.6

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

225

1659

1.38

4.95

2.4

2.2

11.88

12.47

nmol/l

0.48

198

1467

(3016879) Cocaine [Presence] in Urine

449

1.73

4.94

1.8

2.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

261

1.97

4.93

1.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.58

4.76

1.5

1.4

94.41

112.43

ng/l

0.36

(1616796) Gas panel - Central venous blood

618

1.61

4.69

4.1

3.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.68

4.67

2.0

1.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

260

1981

1.34

4.66

2.2

2.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

288

1.89

4.64

1.6

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

346

1.81

4.63

1.6

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

150

1043

1.46

4.59

2.0

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

283

1.89

4.55

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

174

2.14

4.50

2.1

2.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

3.16

4.48

2.9

3.4

153.22

41.01

au/ml

—

(40767503) Oxygen content in Capillary blood by calculation

586

1.61

4.48

2.4

2.5

16.32

15.92

0.35

300

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

299

1.86

4.48

1.8

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

299

1.86

4.48

1.8

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

155

2.21

4.46

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

155

2.21

4.46

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

195

1430

1.39

4.46

11.0

9.1

24.44

24.36

mmol/l

0.11

189

1391

(3000764) Benzodiazepines [Presence] in Urine

487

1.66

4.42

1.8

1.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

143

2.25

4.40

1.1

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.07

4.40

19.1

14.2

6.59

5.44

mmol/l

0.56

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

156

2.19

4.40

1.2

—

(3021901) Oxygen saturation in Capillary blood

511

1.64

4.39

3.0

2.8

—

(3028300) Cannabinoids [Presence] in Urine

488

1.66

4.39

1.8

1.9

—

(3000492) Spirometry study

289

2256

1.31

4.38

1.7

1.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

157

2.18

4.33

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

157

2.18

4.33

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

157

2.18

4.33

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.96

4.29

1.0

1.1

77.50

79.83

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

311

1.82

4.28

1.2

1.3

—

nmol/l

—

(3036180) Methadone [Presence] in Urine

2.85

4.22

1.6

1.7

—

(3027008) Opiates [Presence] in Urine

486

1.64

4.21

1.8

1.9

—

(3028707) Methadone [Presence] in Urine by Screen method

214

1.98

4.16

2.4

2.6

—

(3003338) MCHC [Mass/volume]

2155

20477

1.18

4.14

28.6

20.0

331.43

331.88

g/l

1.49

2141

20310

(40761536) Microorganisms panel - Urine sediment

271

2115

1.31

4.13

6.0

4.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.99

4.12

3.2

4.0

12.22

7.98

mg/l

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

152

1086

1.42

4.06

4.4

4.0

24.63

24.81

mmol/l

0.30

140

1001

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

603

1.56

4.01

1.5

1.3

—

(3027944) Amphetamines [Presence] in Urine

478

1.63

3.98

1.9

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.44

3.96

2.1

2.0

69.47

60.21

ug/l

0.18

(3044941) Cell count panel - Synovial fluid

417

1.67

3.96

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

357

1.72

3.93

1.2

1.3

0.16

0.40

nmol/l

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

464

1.63

3.93

4.3

3.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

112

2.33

3.92

1.3

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

395

3252

1.25

3.91

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

382

1.69

3.85

2.0

—

(3045424) Erythrocytes [Presence] in Urine

436

1.64

3.84

1.5

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.69

3.82

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

377

1.69

3.76

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

108

2.33

3.75

1.1

1.3

161.00

154.52

mmol/24h

0.14

108

(3007566) Smooth muscle Ab [Titer] in Serum

655

1.51

3.71

1.2

206.25

100.67

titre

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

202

1538

1.34

3.68

1.4

1.3

—

(3002256) Pathology report gross observation

410

3412

1.23

3.68

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

135

2.16

3.67

1.3

1.08

1.05

nmol/l

0.04

104

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

155

1133

1.39

3.66

2.2

1.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

103

2.34

3.66

1.7

2.5

74.50

155.36

umol/l

1.14

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.43

3.63

1.5

1.4

—

(3019977) pH of Arterial blood

143

2.11

3.58

1.8

2.8

7.43

7.42

—

(3024869) Neuronal Ab [Presence] in Serum

2.95

3.57

1.0

1.1

—

(3042631) Mycobacterium sp identified in Specimen

384

1.65

3.53

3.0

2.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

398

3319

1.23

3.51

5.2

4.7

33.04

32.97

0.04

270

2200

(3035320) C reactive protein [Mass/volume] in Body fluid

158

2.04

3.50

2.9

2.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

347

1.68

3.49

1.4

1.2

4.79

4.36

u/ml

0.08

118

(3020630) Protein [Mass/volume] in Serum or Plasma

293

2363

1.27

3.48

2.2

2.6

65.64

66.30

g/l

0.88

273

2155

(3006184) Hemoglobin [Mass/volume] in Capillary blood

600

1.52

3.47

2.3

2.2

128.28

128.13

g/l

0.02

432

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

315

2565

1.25

3.45

2.5

2.2

0.21

g/l

0.54

291

2382

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

387

1.64

3.44

1.3

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

201

1.90

3.43

2.3

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.99

3.41

1.1

—

(3012501) Base excess in Blood by calculation

611

1.50

3.40

4.4

4.7

2.63

2.66

mmol/l

0.04

425

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

389

1.63

3.38

1.3

1.2

—

(3010421) pH of Blood

105

729

1.46

3.33

4.8

4.4

7.42

0.57

663

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

119

846

1.42

3.33

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

247

1.79

3.32

1.3

62226.71

88562.06

e6/l

0.16

171

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.43

3.31

7.2

5.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

567

1.51

3.28

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

169

1.96

3.28

1.4

1.37

1.15

promille

0.37

125

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

124

892

1.41

3.25

2.9

3.3

1.22

1.59

ratio

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

150

2.01

3.20

1.2

1.1

0.25

3.63

nmol/l

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.38

3.18

5.4

—

(3000012) Reticulocyte production index

420

1.58

3.15

2.5

2.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.47

3.12

1.5

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

180

1.90

3.09

2.0

2.2

13.88

15.57

0.42

173

(3018405) Lactate [Moles/volume] in Arterial blood

136

1005

1.37

3.06

5.0

3.8

1.56

1.36

mmol/l

0.88

131

989

(3022621) pH of Urine by Test strip

218

1725

1.28

3.05

3.5

3.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

570

1.49

3.02

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

694

1.44

3.02

3.0

3.4

—

(3004616) Nuclear Ab [Presence] in Serum

301

1.67

2.99

1.3

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

426

1.56

2.99

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

450

1.55

2.98

3.6

3.4

1.68

1.37

0.24

395

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

10.01

2.98

2.2

2.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.24

2.96

1.3

1.1

—

(3024928) Oxygen saturation in Venous blood

549

1.49

2.94

6.7

3.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

125

918

1.38

2.94

2.9

3.3

35.97

69.87

mg/l

1.35

101

743

(3034860) Kappa light chains.free [Mass/volume] in Serum

125

920

1.37

2.90

2.9

3.3

40.43

121.37

mg/l

0.71

102

741

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.45

2.89

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

584

1.47

2.89

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.71

2.88

2.5

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

275

1.68

2.84

3.9

3.5

54.00

56.27

0.28

229

(40768441) Liver Pathology biopsy report

186

1.84

2.83

2.0

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

513

1.49

2.82

1.8

1.6

322.86

302.88

mu/l

0.15

469

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

187

1.83

2.78

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

306

2547

1.22

2.78

1.8

1.45

1.51

0.90

258

2199

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

331

1.61

2.77

1.2

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

3.92

2.77

12.4

10.8

—

(3028433) Virus identified in Specimen by Culture

2.32

2.74

1.1

1.3

—

(3047181) Lactate [Moles/volume] in Blood

119

879

1.37

2.72

6.3

1.34

1.33

mmol/l

0.02

107

766

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.37

2.72

1.8

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.37

2.72

1.8

2.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

341

1.59

2.71

1.4

1.2

5.60

5.17

u/ml

0.06

155

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

341

1.59

2.71

1.2

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

349

1.59

2.71

1.2

1.4

—

(3051651) Icteric interference index of Serum or Plasma

160

1.88

2.71

4.4

3.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

132

1.98

2.70

1.2

1.1

—

(4034850) Laboratory test

115

848

1.37

2.66

14.3

10.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

695

1.41

2.66

2.0

1.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

343

1.58

2.65

1.2

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

344

1.58

2.62

1.2

1.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

2.26

2.60

2.1

2.3

30.50

28.11

0.25

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

560

4952

1.16

2.56

3.4

3.1

0.66

0.78

ug/l

3.39

381

3412

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

149

1.89

2.56

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

135

1.93

2.55

2.2

2.6

38.42

40.71

0.27

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

284

1.63

2.54

4.1

3.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

693

1.40

2.54

1.5

1.4

30.44

31.95

iu/l

0.14

595

(3025468) Yersinia sp identified in Specimen by Organism specific culture

340

1.57

2.51

1.2

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

115

2.01

2.50

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.39

2.46

1.2

1.5

54.33

187.51

nmol/24h

0.72

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

123

1.96

2.45

1.5

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

123

1.96

2.45

1.5

1.6

—

(1002224) Polysomnography panel

110

818

1.36

2.44

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

151

1177

1.30

2.43

1.8

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

345

1.55

2.38

1.2

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

228

1.68

2.36

1.4

1.3

36.70

29.98

u/l

0.52

186

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.51

2.35

1.8

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

184

1477

1.26

2.35

12.5

9.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

346

1.54

2.35

1.2

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

510

1.44

2.34

1.3

1.8

0.79

0.83

nmol/l

0.21

420

(3034891) Synovial lining cells/100 cells in Synovial fluid

112

1.97

2.30

2.2

1.4

3.78

1.77

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

148

1.83

2.28

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

223

1.67

2.27

1.4

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

223

1.67

2.27

1.4

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

223

1.67

2.27

1.4

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

392

3405

1.17

2.26

9.4

7.3

—

(3011288) Drugs identified in Urine by Screen method

326

1.54

2.24

2.2

2.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.28

2.24

1.3

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.24

2.17

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.69

2.15

1.0

1.4

—

(3037121) Protein [Mass/volume] in Urine

123

952

1.30

2.12

4.0

3.2

0.42

0.29

g/l

0.71

391

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

102

1.97

2.10

1.1

1.2

309.18

211.24

iu/ml

0.31

102

(3023511) Choriogonadotropin [Units/volume] in Urine

190

1.69

2.10

1.2

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

221

1.64

2.09

1.7

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

608

1.38

2.07

1.1

8.00

5.65

u/ml

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.01

2.07

1.0

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

333

1.51

2.06

1.2

1.1

106.95

114.71

0.68

302

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.99

2.05

2.7

2.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.11

2.02

1.3

1.2

36.85

38.78

g/l

—

(3020891) Body temperature

142

1131

1.27

1.98

6.3

4.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

148

1.76

1.98

1.7

2.4

0.24

0.22

e9/l

0.27

130

(3027974) Hepatitis B virus e Ag [Presence] in Serum

4.55

1.94

1.2

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.55

1.94

1.2

1.5

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

4.55

1.94

1.0

1.1

9.50

7.68

mmol/l

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

127

1.82

1.93

1.4

1.2

1.03

1.05

ratio

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.97

1.93

1.1

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

1110

1.26

1.91

2.6

2.3

3.50

3.67

g/l

1.13

127

1004

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

131

1039

1.27

1.90

2.6

2.3

9.58

10.30

g/l

1.24

119

922

(3032057) Clostridioides difficile [Presence] in Stool

2.25

1.90

1.8

2.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

1112

1.26

1.89

2.6

2.3

7.25

7.43

g/l

0.64

127

1004

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

1112

1.26

1.89

2.6

2.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

357

1.46

1.88

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

114

1.85

1.87

1.0

1.3

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

244

1.56

1.87

2.7

2.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

341

2979

1.16

1.86

3.2

4.0

7.40

23.66

ug/l

2.91

270

2443

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

100

1.91

1.85

1.4

1.7

2.93

10.45

nmol/l

0.89

(3029075) Extractable nuclear Ab panel - Serum

2.21

1.84

1.1

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

570

1.36

1.84

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

570

1.36

1.84

1.4

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

3.53

1.83

1.0

1.2

—

(3004451) EKG impression Narrative

145

1.73

1.81

1.3

—

(40768793) Breast Pathology biopsy report

596

0.67

1.80

1.5

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

199

1.61

1.80

1.9

1.4

0.30

0.29

nmol/l

0.04

148

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

765

1.30

1.78

1.9

1.7

2.72

3.88

mg/l

0.64

567

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

146

1.72

1.77

3.7

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

146

1.72

1.77

3.7

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

169

1.66

1.77

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

224

1.57

1.76

2.0

1.5

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

256

1.53

1.76

1.4

1.6

—

1506.67

—

(3044290) Cell count panel - Cerebral spinal fluid

498

1.37

1.75

1.2

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.34

1.74

1.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

250

1.53

1.70

1.5

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.30

1.70

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

171

1.64

1.70

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.06

1.70

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

168

1393

1.22

1.68

5.1

3.5

—

(3051611) Lipemic interference index of Serum or Plasma

292

1.48

1.67

4.2

3.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.03

1.64

1.7

1.3

12.25

8.87

ug/l

1.25

(3024263) Appearance of Synovial fluid

142

1.70

1.64

1.3

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.98

1.64

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

127

1.74

1.64

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

127

1.74

1.64

1.2

1.4

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

3.58

1.61

1.6

1.9

31.04

21.59

mg/l

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.15

1.61

1.1

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

463

1.37

1.61

1.5

1.3

13.87

10.79

u/l

0.88

376

(3041354) Potassium [Moles/volume] in Venous blood

353

1.42

1.60

2.6

2.3

4.06

4.07

mmol/l

0.05

347

(1761868) Lipid panel - Serum or Plasma

860

8024

1.10

1.60

3.4

3.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.91

1.59

1.3

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.33

1.58

1.0

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

191

1.58

1.57

1.2

1.1

—

3.83

—

(3052592) Norovirus Ag [Presence] in Stool

2.20

1.57

1.5

1.4

—

(3034426) Prothrombin time (PT)

1.93

1.54

1.2

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

390

1.39

1.54

2.0

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.98

1.53

1.1

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

115

1.74

1.52

1.4

1.2

—

66.13

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

127

1036

1.24

1.51

2.5

2.4

2.83

2.96

g/l

0.88

115

929

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

201

1.55

1.51

1.2

1.1

—

64.57

—

(3016018) Differential panel - Cerebral spinal fluid

258

1.48

1.50

1.1

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.87

1.50

2.1

2.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

282

2475

1.15

1.48

1.5

1.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

178

1.58

1.48

1.8

1.5

83.39

86.52

umol/l

0.14

178

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

179

1.57

1.45

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

352

1.40

1.45

3.2

2.2

17.64

24.68

mg/l

1.13

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.12

1.44

1.0

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

353

1.39

1.43

2.6

2.3

106.39

105.29

mmol/l

1.01

347

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.73

1.43

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

125

1.68

1.43

1.3

1.2

146.81

137.82

nmol/l

0.38

125

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.04

1.43

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

154

0.45

1.42

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

457

1.34

1.41

1.1

1.3

49.92

37.46

u/l

0.31

395

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.18

1.40

1.3

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.78

1.38

1.2

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.20

1.37

1.0

1.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.61

1.36

1.5

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

374

1.37

1.36

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

161

0.50

1.35

1.5

1.4

—

(3018572) Chloride [Moles/volume] in Blood

619

1.28

1.34

7.0

7.3

105.11

105.34

mmol/l

0.13

547

(3039000) Anion gap in Blood

619

1.28

1.34

7.0

7.3

11.48

11.19

mmol/l

0.27

547

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

106

861

1.24

1.34

2.1

37.94

37.66

g/l

0.17

753

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

120

1.67

1.34

1.3

1.1

—

(3045142) Bone marrow Pathology biopsy report

316

1.40

1.33

1.4

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.04

1.32

1.0

1.1

0.32

0.69

umol/24h

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

648

1.27

1.31

1.2

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

317

1.39

1.31

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.50

1.30

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.50

1.30

1.3

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

153

1.57

1.28

2.3

1.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.94

1.27

4.5

7.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

210

1.48

1.27

2.6

1.5

28.00

20.60

u/ml

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.72

1.27

1.1

1.0

97.58

91.18

0.45

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

130

1.62

1.26

1.1

1.30

1.17

u/l

—

(3006270) Folate [Moles/volume] in Blood

219

1.47

1.25

1.3

1.2

351.12

366.53

nmol/l

0.15

184

(4146454) Self-monitoring of blood glucose

312

1.38

1.24

2.8

2.7

—

(3044927) Protein electrophoresis panel - Urine

304

1.39

1.23

1.3

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

171

1.52

1.23

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

147

1.57

1.23

2.9

2.1

—

(3016750) Collection duration of Urine

156

1.54

1.20

3.0

2.0

504.25

488.98

min

0.29

113

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

101

1.69

1.19

1.1

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

702

1.25

1.19

2.7

2.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.93

1.17

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

385

1.33

1.16

2.5

2.0

1854.30

3129.97

u/l

0.29

154

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

1.16

0.0

1.2

—

24.73

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

344

1.34

1.12

2.7

2.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

103

1.65

1.12

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

502

1.28

1.12

1.3

1.2

187.15

213.92

miu/ml

0.24

205

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

327

1.35

1.12

1.1

1.56

1.54

g/l

0.09

291

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.90

1.12

1.5

1.4

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

2.26

1.10

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

160

1.50

1.09

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

720

1.23

1.09

7.0

4.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

295

1.36

1.08

1.7

2.0

—

(3037756) Immunofixation for Serum or Plasma

613

1.25

1.07

1.3

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

137

1.54

1.05

1.4

1.7

2.00

2.14

u/field

0.03

(4094501) Cardiovascular stress test using bicycle ergometer

661

1.23

1.04

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

229

1.40

1.03

1.0

1.1

4.00

1.40

u/ml

0.70

119

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

155

1.49

1.01

2.0

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

2.00

1.00

1.7

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

123

1.55

0.99

1.3

1.2

188.53

394.69

u/l

1.13

113

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.71

0.98

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

160

0.56

0.98

1.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.97

0.0

1.6

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.97

0.0

4.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.85

0.96

5.2

7.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

354

1.30

0.96

4.7

5.1

332.26

363.71

umol/l

0.69

304

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.69

0.95

1.0

1.1

—

(21494434) Karyotype in Bone marrow

259

1.36

0.95

1.3

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.65

0.94

1.1

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.65

0.94

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.78

0.94

1.9

1.8

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.22

0.93

1.0

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

101

1.59

0.93

1.9

2.0

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.73

0.92

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

692

6546

1.07

0.92

1.4

1.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.15

0.91

1.0

1.3

—

706.74

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.67

0.91

1.7

2.4

0.95

1.65

ug/l

0.82

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.60

0.90

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

253

1.35

0.90

1.2

1.5

—

(3017569) Oxygen content in Arterial blood

143

1.47

0.89

3.2

2.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.07

0.89

1.5

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.07

0.89

1.5

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.07

0.89

1.5

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

271

1.33

0.89

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

485

1.24

0.87

1.8

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

272

1.33

0.87

1.2

1.1

—

(44813793) Dust mix specific IgE antibody measurement

144

1.46

0.87

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

178

1.41

0.86

1.2

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

128

1.49

0.85

1.1

1.7

—

(3014271) Vancomycin [Susceptibility]

145

1.45

0.84

2.8

3.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.94

0.84

1.0

1.2

1.55

1.84

umol/24h

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.94

0.84

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.57

0.84

1.6

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.57

0.84

1.6

1.7

—

(3008295) Osmolality of Serum or Plasma

283

1.31

0.83

1.4

1.3

279.82

277.28

mosm/kgh2o

0.18

213

(3043238) Trisomy 21 risk [Likelihood] in Fetus

166

0.60

0.83

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1122

0.85

0.83

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.74

0.82

1.4

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

302

1.30

0.81

1.1

1.32

2.12

u/ml

0.35

152

(3008757) Leukocyte morphology finding [Identifier] in Blood

302

1.30

0.81

4.5

3.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

155

1.42

0.81

2.1

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.82

0.79

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.53

0.78

1.6

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

146

1293

1.14

0.77

2.3

3.7

51.68

69.23

u/ml

0.45

137

1246

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.77

0.76

1.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

107

1.50

0.76

1.1

—

7.23

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

108

938

1.16

0.76

2.4

0.46

1.02

g/l

1.80

815

(3013637) Mi-2 Ab [Presence] in Serum

1.64

0.75

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.64

0.75

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.64

0.75

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.64

0.75

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

227

1.32

0.74

2.8

5.0

48.49

53.16

u/ml

—

(3017704) Immunofixation for Urine

158

1.40

0.74

1.2

1.6

—

(3011648) Oxygen content in Venous blood

201

1.35

0.74

3.3

2.9

11.28

11.09

0.08

201

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.64

0.73

1.8

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

254

1.30

0.73

2.2

3.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.00

0.72

1.8

2.9

0.40

0.72

u/field

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.00

0.72

5.2

1.8

21.58

18.91

umol/l

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.67

0.72

1.4

1.0

308.40

273.98

pmol/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.55

0.71

1.0

1.1

—

(3003129) Base excess in Capillary blood by calculation

1.58

0.71

1.7

2.0

-2.19

1.20

mmol/l

1.36

(3051593) INR in Capillary blood by Coagulation assay

134

1.42

0.71

4.8

13.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.92

0.70

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

177

1.36

0.70

2.0

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

205

0.68

0.69

1.3

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

675

1.17

0.69

1.3

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

546

1.19

0.69

1.2

1.5

3.49

23.82

e6/l

1.38

424

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

546

1.19

0.69

1.2

1.5

240.55

1112.24

e6/l

1.90

446

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

118

1.44

0.69

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

153

1703

0.89

0.69

1.9

1.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

302

1.26

0.67

1.3

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

170

1.36

0.67

1.4

1.3

—

70.00

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

191

0.68

0.66

1.4

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.79

0.66

2.0

1.2

—

(3035880) pH of Pleural fluid

167

0.66

1.7

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

145

1.38

0.65

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.54

0.65

1.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

358

1.23

0.65

1.4

1280.32

1753.29

e6/l

0.55

259

(4035726) Immunohistochemistry procedure

257

2378

1.09

0.64

1.5

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

260

1.27

0.64

1.0

1.1

8.56

3.46

u/ml

0.67

116

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

146

1.37

0.63

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

333

1.23

0.62

2.3

31.21

939.79

u/ml

0.61

327

(3003181) Sodium [Moles/volume] in Urine

507

1.19

0.62

1.4

1.3

69.68

64.21

mmol/l

0.44

402

(3039443) Prostate specific Ag panel - Serum or Plasma

434

0.80

0.60

1.8

1.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

218

1.29

0.60

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

218

1.29

0.60

1.3

2.1

0.83

2.00

u/field

1.53

(3028308) Erythrocytes [#/volume] in Pleural fluid

318

1.23

0.58

1.5

1.4

28782.38

83211.87

e6/l

1.22

186

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

246

1.26

0.58

1.4

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

202

1.29

0.57

1.3

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.67

0.56

2.0

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.51

0.56

1.4

2.1

—

(40768800) Prostate Pathology biopsy report

560

1.16

0.55

1.1

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

160

1.31

0.53

1.0

0.10

0.33

u/ml

—

(3016038) Potassium [Moles/volume] in Urine

178

1.29

0.53

1.1

1.2

32.74

33.91

mmol/l

0.09

150

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

192

0.73

0.52

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

192

0.73

0.52

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

161

1.31

0.51

1.1

41.07

42.73

mg/l

0.07

133

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.50

0.51

6.8

7.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

251

1.24

0.51

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

659

1.14

0.50

2.6

2.2

88.98

100.79

ug/min

0.14

396

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

191

0.73

0.50

1.4

—

(21494755) Public health laboratory ask at order entry panel

144

1573

0.91

0.50

1.3

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

180

1.28

0.49

1.0

1.1

2.98

3.11

u/ml

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

145

1.31

0.48

1.3

1.4

103.00

218.87

pmol/l

1.07

145

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

145

1.31

0.48

1.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

217

1.25

0.48

2.9

2.2

653.67

629.09

0.11

138

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

137

1.32

0.47

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

137

1.32

0.47

1.2

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

1.46

0.46

3.3

5.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

291

1.21

0.46

1.0

1.1

1.15

2.02

u/ml

1.64

121

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.43

0.46

1.0

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.40

0.45

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

629

1.13

0.44

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

130

0.69

0.43

1.1

1.3

1.74

1.59

g/l

—

130

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.41

0.43

1.1

1.2

—

19.31

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.61

0.43

1.0

—

(40765096) Chromosome analysis panel by Banding

0.64

0.42

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

131

1.30

0.42

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

0.63

0.42

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.36

0.41

1.5

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.47

0.40

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

2.1

—

29.12

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

115

1.31

0.38

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.39

0.38

1.0

1.2

36.52

55.09

mg/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.34

0.38

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

197

1.22

0.37

1.0

1.1

4.76

2.39

u/ml

0.30

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

271

1.18

0.37

1.2

1.3

7.80

7.48

mmol/l

0.12

232

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

111

1022

1.09

0.37

2.5

3.4

17.06

4281.99

u/ml

0.92

863

(3022689) Creatine [Moles/volume] in Urine

1.39

0.37

1.7

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

301

1.16

0.35

2.4

2.2

1.30

1.19

g/24h

0.07

148

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

341

0.85

0.34

1.6

1.5

—

(3000285) Sodium [Moles/volume] in Blood

1.36

0.34

1.5

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

164

1.22

0.32

2.0

1.5

0.88

0.97

g/l

1.10

164

(3005570) Glucose [Moles/volume] in Urine

274

0.84

0.32

2.2

1.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

156

1.22

0.31

3.9

6.6

—

(40768806) Pleura Pathology biopsy report

305

1.15

0.30

1.8

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

241

1.16

0.29

3.7

3.1

84.60

36.02

mg/l

0.51

179

(40768795) Lymph node Pathology biopsy report

248

0.85

0.28

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

150

1.20

0.26

1.1

—

(3020650) Glucose [Presence] in Urine

1.25

0.25

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.25

0.25

1.3

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

254

1.14

0.25

1.0

1.1

0.36

1.68

u/ml

1.15

102

(3025130) Human papilloma virus identified in Specimen

226

1.15

0.25

1.8

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

142

1.20

0.24

5.1

3.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

169

0.83

0.24

1.4

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

169

0.83

0.24

1.6

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.75

0.22

1.1

1.4

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.05

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.21

0.0

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.21

0.0

1.0

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

1.23

0.21

1.2

1.6

1.86

1.93

umol/l

0.12

(3012441) Differential panel - Pleural fluid

297

1.11

0.20

1.8

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

108

1.20

0.20

2.1

2.2

43.27

48.05

umol/l

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

114

0.79

0.20

1.1

5.7

—

60.27

—

(3035933) Granulocytes/100 leukocytes in Blood

1.18

0.19

3.2

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.13

0.18

1.3

2.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

251

1.12

0.18

1.6

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

347

1.10

0.18

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.13

0.17

2.0

2.6

—

(40757373) Influenza virus identified in Isolate

1.16

0.16

1.3

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.11

0.16

1.0

2.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

151

0.86

0.15

1.9

1.7

—

(3006462) Nitrate [Presence] in Urine

119

0.84

0.15

4.4

3.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

121

1.16

0.15

1.6

1.5

—

(3048879) Bone marrow aspiration report

1.08

0.14

1.3

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.08

0.14

1.3

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

123

1.14

0.12

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

152

1.12

0.12

1.6

2.2

13.90

11.22

umol/l

0.09

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

173

1.10

0.10

1.9

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.11

0.09

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

243

1.07

0.08

1.6

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.03

0.08

2.0

1.3

—

(3020491) Glucose [Moles/volume] in Blood

185

1.08

0.08

1.8

2.2

7.30

6.92

mmol/l

0.33

120

(3033799) Differential panel - Peritoneal fluid

1.14

0.08

2.7

2.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

588

1.04

0.08

3.9

3.5

30.40

27.58

mg/l

0.17

360

(3044007) Cell count panel - Peritoneal fluid

0.86

0.07

2.1

2.0

—

(3045788) Cell count panel - Pleural fluid

285

1.05

0.06

1.4

—

(4281824) Cell count and differential, peritoneal fluid

287

1.05

0.05

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

387

1.03

0.04

1.1

47.33

86.18

iu/ml

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

119

0.92

0.04

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

301

0.96

0.03

1.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

151

1.06

0.03

2.4

2.1

127.71

174.39

ug/min

—

(3047189) Immunofixation for 24 hour Urine

132

1.06

0.02

1.9

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

932

0.99

0.02

1.9

1.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

262

1.03

0.02

1.7

1.3

256.99

347.56

u/l

0.74

250

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

114

1.05

0.00

11.8

13.2

784.42

792.06

nmol/l

0.02

108

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

204

1.03

0.00

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

195

0.97

0.00

1.0

44.40

45.32

ng/l

0.03

122

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

136

1.03

0.00

2.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

194

0.98

0.00

1.0

344.00

318.71

ng/l

0.17

125

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

194

0.98

0.00

1.0

773.43

676.43

ng/l

0.42

122

(3023410) Appearance of Cerebral spinal fluid

247

1.01

0.00

1.3

1.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

187

1.02

0.00

1.8

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.88

-0.00

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

5.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.98

-0.00

1.2

1.3

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

-0.00

0.0

2.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

210

1.00

-0.00

1.1

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.0

—

395.38

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3008607) Semen analysis panel

0.00

-0.00

0.0

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

1.49

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

2.6

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

12.64

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

577.16

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

0.98

-0.00

1.9

1.4

2.09

3.26

mmol/l

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_CONJUHAEMOR and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_CONJUHAEMOR	1.172 [1.04, 1.32]	0.01
Birth year	0.993 [0.98, 1.0]	0.107

During the follow-up period (1.1.1998 — 31.12.2019), 1283 out of 7818 females with H7_CONJUHAEMOR died.

Males

Parameter	HR [95% CI]	p-value
H7_CONJUHAEMOR	1.187 [1.05, 1.35]	0.008
Birth year	0.991 [0.98, 1.0]	0.054

During the follow-up period (1.1.1998 — 31.12.2019), 1396 out of 6926 males with H7_CONJUHAEMOR died.

Mortality risk

Mortality risk for people of age

years, who have H7_CONJUHAEMOR.

N-year risk	Females	Males
1	0.108%	0.274%
5	0.597%	1.553%
10	1.715%	3.803%
15	3.438%	7.197%
20	5.735%	12.1%

Relationships between endpoints

↥

Index endpoint: H7_CONJUHAEMOR – conjunctival haemorrhage

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

conjunctival haemorrhage

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints